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Background: Although a decline in smoking prevalence is seen in most developed 
countries, smoking during pregnancy remains an important public health concern, 
affecting both the mothers’ own health as well as that of her unborn child. 
Objectives: The objective was to study several aspects of smoking habits among 
pregnant women in Norway since 1999. Firstly, to assess changes and secular trends 
in smoking habits during pregnancy in the period 1999-2004. Secondly, to 
biochemically assess the validity of self-reported smoking habits in the Norwegian 
Mother and Child Cohort Study (MoBa). The third objective was to explore if women 
born with low birth weight more often end up as smokers as adults compared to 
women born with higher birth weight. The fourth aim was to assess the risk of small 
for gestational age (SGA) in 2nd pregnancy according to smoking habits in two 
successive pregnancies.  
Methods: Main data sources included The Medical Birth Registry of Norway with 
links to other registries (paper I: 1999-2004, paper III: 1967-2014 and paper IV: 
1999-2014) and the MoBa (paper II: 2002-2003). Cross sectional files as well as 
generational and sibling files were used to pursue the objectives. 
Results: The overall daily smoking prevalence among Norwegian pregnant women 
decreased from 18% in 1999 to 11% in 2004 (Relative Risk (RR) 0.61, 95% 
Confidence Interval (CI) 0.58, 0.64)). The decline was observed in all subgroups. 
Maternal educational level was strongly associated with smoking at the end of 
pregnancy. More women quit smoking during pregnancy in the second half of the 
study period, compared to the first. 
Among a subsample of 2 997 women in MoBa an overall mean sensitivity of 
81.9% (95% CI 77.3, 86.4) and specificity of 99.4% (95% CI 99.1, 99.7) was 
calculated for self-reported smoking habits with plasma cotinine concentrations as the 
gold standard.  
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For the association between birth weight and later smoking habits we found 
that women born at term with low birth weight (<2000 grams) more often smoked at 
the end of their pregnancies compared with women born with higher birth weights (4 
000-4 499 grams) (RR 1.8 (95% CI 1.4, 2.2)). We observed a similar trend between 
men’s birth weight and their partners’ smoking habits in pregnancy (RR 1.5 (95% CI 
1.2, 2.0)).  
Daily smokers throughout the first pregnancy, who abstained throughout their 
second pregnancy, had a 1.3 increased risk of SGA in the second pregnancy (95% CI 
1.1, 1.6), compared to persistent non-smokers. About two-fold risks were found for 
women who smoked daily throughout their first pregnancy, but had quit by the end of 
the second pregnancy (RR 2.0 (95% CI 1.6, 2.4)) and for women who were non-
smokers in the first pregnancy and daily smokers in their second (RR 1.8 (95% CI 
1.4, 2.3)). Persistent smokers through both pregnancies had a 2.9 fold increased risk 
(95% CI 2.7, 3.1). Persistent smoking women who did not experience SGA in their 
first pregnancy, had a 2.7 fold increased risk of SGA in the 2nd pregnancy (95% CI 
2.5, 3.0).  
Conclusions and implications: Smoking during pregnancy declined during 1999-
2004 in all subgroups, and maternal educational level was a strong indicator for 
smoking at the end of pregnancy. Self-reported smoking is a valid indicator of 
intrauterine exposure to tobacco smoke among participants in MoBa. Being born with 
low birth weight is associated with smoking in adulthood. This suggests a shared 
smoking environment through generations, and may account for some of the 
established association between birth weight and cardiovascular disease. Smoking 
information from both the beginning and the end of a pregnancy is important for 
adequate risk assessment of SGA in 2nd pregnancy. Persistently smoking women 
throughout two successive pregnancies had the highest risk of SGA in 2nd pregnancy. 
Women who smoked throughout both pregnancies with no previous SGA were not 
protected against SGA in the 2nd pregnancy. 
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Tobacco is a legal consumer product that might kill its users even when used as 
intended by manufacturers,1 and no level of use during pregnancy is considered safe. 
Worldwide, more than a billion people smoke tobacco.2 The global overall smoking 
prevalence (among the population older than 15 years) has dropped from 24% in 
2007 to 21% in 2015, with much of the decline occurring in high-income countries. 
However, because of population growth, the number of people still smoking has 
remained stable since 2007.2   
Tobacco products are complex combinations containing over 4 000 chemicals 
with several different toxic constituents, and with nicotine causing and sustaining 
addiction to tobacco products.3 Nicotine in tobacco smoke is rapidly delivered 
through the large surface area of the alveoli and small airways to the systemic 
circulation and reaches the brain, stimulating nicotinic acetylcholine receptors in the 
central nervous system. The addictive behaviour can be seen as a neurobiological 
adaption to chronic nicotine exposure with several transmitter systems involved.4  
Other constituents in tobacco smoke have been identified as compounds causing 
cancer, as respiratory irritants and as constituents with cardiovascular effects. 5   
Even though the harm of tobacco products have been known for more than 60 
years, the pace of the decline in smoking prevalence globally has been described as 
“remarkably slow”.6-8 Globally in 2016, smoking was the second most important risk 
factor for death for men and the sixth for women, attributable to 16% and 6% of 
deaths, respectively.8 
In 2015, the global smoking prevalence of women was 8%.2 Today the hazards 
of smoking on females’ longevity are well known and include excess mortality from 
diseases such as chronic lung disease, lung cancer, heart disease and stroke.9 
However, novel associations are still being found between tobacco smoking and 
mortality from diseases that have not currently been established as caused by 
smoking.10 
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A healthy pregnancy is of great importance to the health of a new born. Since 
Winea Simpson published a possible effect of maternal smoking on fetal growth  in 
1957,11 the knowledge concerning harms of tobacco in pregnancy has greatly 
expanded. Maternal smoking during pregnancy has since then been shown to cause 
pregnancy complications such as ectopic pregnancy,4,12 spontaneous abortion13 
(though consensus has not been reached4,13,14) and placental abruption15 and affect 
developmental endpoints such as fetal size (small for gestational age (SGA))16,17 and 
growth,18 preterm birth (before 37 gestational weeks),15,19 stillbirths,20,21 neonatal and 
perinatal death,21 sudden infant death syndrome22-25 and oral clefts.4,26 Some of the 
adverse pregnancy outcomes associated with maternal smoking are shown in table 1. 
Estimates of relative risks and odds ratios associated with maternal smoking during 
pregnancy are ranging from lowest of around 1.1 for neonatal death to two- to 
fourfold for sudden infant death syndrome. Maternal smoking during pregnancy is 
also related to asthma and wheezing in children.27 Studies have found effects of 
maternal smoking during pregnancy on brain structure and function.28 However, 
environmental and genetic factors may confound the association.4,29 Smoking is 
paradoxically shown to reduce the risk of preeclampsia.30 However, among pregnant 
women with preeclampsia, smoking increases the risks of perinatal mortality, 
abruptio placenta and SGA.30  
Table 1. Summary of published associations between smoking and adverse outcomes 
Adverse pregnancy outcomes Relative risks or Odds ratios 
Ectopic pregnancies 4,12 1.7  -  1.9 
Placental abruption 15 1.4  -  2.4 
Small for gestational age 15-17 1.5  -  2.9 
Preterm birth 15,19 1.2  -  1.6 
Stillbirth 20,21 1.4  -  1.8 
Neonatal death 21 1.1  -  1.3 
Perinatal death 21 1.3  -  1.4 
Sudden infant death syndrome 23-25 2.4  -  4.1 
 
 
Despite a declining prevalence in most developed countries, smoking during 
pregnancy continues to be an important public health problem. For the strategic 
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period 2013-2016,  the Norwegian government (The Ministry of Health and Care 
Services), with the strategic plan “A tobacco-free future”, had a goal of reaching a 
smoking prevalence of less than 4 % among pregnant women by the end of the 
pregnancy.31 The strategy has been extended to be valid through 2017. The vision of a 
tobacco-free future is described as “a future in which individuals and communities 
are no longer affected by tobacco’s many harmful effects on health and where 
children and adults live healthier and longer lives”.31 A further goal in the strategy is 
that children born after year 2000 should not start smoking or using snus.31  
In order to be able to address the problem and intervene, it is vital to 
understand the extent of maternal tobacco use. This requires nationally updated 
representative data. In 2016, the Medical Birth Registry of Norway (MBRN) had 
information on smoking habits from 92% of women giving birth and reported a daily 
smoking prevalence of  3.8% at the beginning of pregnancy and 2.7% at the end of 
pregnancy.32  Continuous registration of the prevalence of maternal smoking during 
pregnancy is important for confounder control in different studies exploring 
associations with adverse pregnancy outcomes as well as for identifying women for 
whom extra efforts may be needed to increase smoking cessation rate. 
Smoking during pregnancy remains a serious public health concern, affecting 
both the mothers’ own health as well as that of her unborn child. The severity of 
compromising the next generation by smoking during pregnancy calls for both 
attention and action. Tobacco smoking is an important preventable risk factor for 
poor pregnancy outcomes.33,34 
The literature search for the present thesis was finalized November 2017. 
1.1 Smoking habits in the Norwegian population 
Smoking prevalence has been defined as “the percentage of daily smokers in a 
population”.15 The tobacco epidemic has been described to follow 4 stages which 
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illustrate the historical evolution of tobacco consumption and tobacco related disease 
in the span of a century (Figure 1).35  
 
Figure 1. A model of the cigarette epidemic. Reproduced from Tob Control Lopez AD, 
Collishaw DE, Tapani P, 242-7, 1994 with permission from BMJ Publishing Group Ltd. 
 
The first stage starts with uptake of cigarette smoking among men, either 
equally in all sociodemographic groups or slightly more among men with higher 
education. By the end of stage 3, smoking is considered socially unfavourable and the 
declines in smoking prevalence are greater among the higher educated population.  
The model characterizes the differential uptake of cigarette smoking among men and 
women in a population, with women characteristically lagging behind men with one 
to two decades. Further, it displays how the increase in prevalence of smokers 
exceeds the increase in smoking related mortality by three to four decades.35 It has 
been suggested that the model should describe men and women separately for 
accurately capturing the tobacco epidemic in developing countries.36 The universal 
feature of the model lies in the delayed effect of uptake of cigarette smoking on 
mortality, rather than the temporal gender differences.36 The model can be used to 
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illustrate how the tobacco epidemic proceeded in Norway, all the way to the fourth 
and last phase. 37  
Mass production of cigarettes started in the early 1900s in Norway, which 
gradually changed the market share from chewing tobacco to smoking tobacco.38 The 
smoking prevalence among Norwegian men and women has progressed differently. 
Statistics Norway (SSB) has collected data on smoking habits in the Norwegian 
population since 1973.39 Information on smoking prevalence prior to this was 
collected by the Cancer Registry in Norway and a commercial pollster (Nielsen 
Norway).40 From the 1930s  to 1960 the smoking prevalence remained about 65% 
among men, while about 5% of women smoked at the beginning of the period, with 
an increase to 35% in 1975. The highest peak prevalence occurred for men born in 
1925-1929 who reached a peak of 78% smoking prevalence when they were 20-24 
years old. For women, the highest smoking prevalence was at 52% among the 1940-
1944 cohort when they were 25-29 years old, and the 1945-1949 cohort when they 
were 20-24 years old.40 While smoking prevalence decreased since the mid 1950’s 
among men,41 the prevalence among women remained around 30% and started to 
drop after year 2000.  Since then similar trends for men and women have been seen,42 
and in 2016 the percentage daily smoking women between 16 and 74 years was 11% 
(Figure 2).  In the recent years the lowest smoking prevalence has been observed 
among men and women aged 16-24 years.39  
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Figure 2. Percentage of daily smokers in the general population in Norway 1973-2016.  
Data from Statistics Norway (ssb.no). 
 
While there has been a very positive trend that the youngest generations smoke 
less tobacco, there has been a rise in snus use (low-nitrosamine smokeless tobacco, 
also called moist snuff). Since 2008 (when SSB started registration) snus use has 
increased most among women aged 16-34 years.43  
1.2 Social inequality in smoking habits 
The socioeconomic status associated with smoking is described to be reversed from 
the start to the end of the tobacco epidemic.44 The daily smoking prevalence among 
Norwegian doctors were more than halved from the 1950s to the 1970s (from 74% to 
35% for men and from 44% to 22% for women).45 While there was a decline in the 
general male population in this period, it was not of the same magnitude as for male 
doctors. For women in the general population there was an increase during this 
period. Smoking has gradually become a habit more common among those with short 
education.43,44 The social gradient in smoking habits obstructs the prospects of 
 21
equality in health in the popoulation.46 Men and women with high education have 
presently the lowest daily smoking prevalence with 4% and 6%, respectively. 
However, the greatest decline in smoking prevalence is now found among those with 
low education, from 34% in 2006 to 13% in 2016.43 Among different measures of 
socioeconomic status, education has been shown to be tightly linked as an 
explanatory variable for smoking.46,47   
While snus use is increasing among women in all educational levels, women 
with low education have the highest prevalence (2% in 2008 and 8 % in 2016). 
However, the increase is most pronounced among women with high education (from 
not measurable in 2008 to 5 % in 2016).39,43  
1.3 Smoking during pregnancy among women in Norway 
Smoking habits among pregnant women have been registered in The Norwegian 
Medical Birth Registry since 1999. Earlier available data on the smoking prevalence 
among Norwegian pregnant women were reported from studies of different size and 
settings in Norway. The daily smoking prevalence reported among pregnant women 
at the end of pregnancy were 26% in 1978,48 34% in 1978/79,49 43% in 1980-1982,50 
and 35%  in 1987/1988.51 The reported daily smoking prevalence at 18 weeks 
gestation was 34% in 1987 and 22% in 1994, this decline was the first reported 
significant reduction in smoking prevalence among Norwegian pregnant women.52 
Figure 3 displays the smoking prevalence among pregnant women in different 

























        
Figure 3. Proportion of reported daily smoking among pregnant women in Norway, 
published before national collection of data in the MBRN.48-52  
 
The daily smoking prevalence at the end of pregnancy has since then fallen to 
2.3% in 2016 in national data from the MBRN.32 While the youngest women in the 
general population have had the lowest daily smoking prevalence in later years, teen 
mothers (<20 years) have had the highest smoking prevalence among pregnant 
women ever since smoking habits in pregnancy were first registered in the MBRN in 
1999.32 In 2014, around 10% of pregnant women younger than 25 years smoked 
through pregnancy, compared to a 4% smoking prevalence among women below 25 
in the general population.53 Also among pregnant women the socioeconomic 
differences in smoking prevalence are evident, with increasing differences in 
smoking prevalence across socioeconomic groups.54,55 Snus use is not registered for 
pregnant women in the MBRN. Only one regional study has been published on 














1.4 International comparisons of smoking prevalence among 
pregnant women 
In the 1980’s, the smoking prevalence in early pregnancy in Norway and Sweden was 
39% and 30%, respectively.57,58 At the same time period about 40% of pregnant 
women in Denmark also smoked during pregnancy.59 Since then, smoking among 
Danish and Swedish pregnant women has decreased to 7% (2016)60 and 4% (2014)61, 
respectively. In Finland, smoking in early pregnancy remained around 15-16% from 
1987 through 2015, but reached 14% in 2016.54,62,63 
In the United States, 40% of White women and 33% of Black women smoked 
during pregnancy in 1967.64 In 2014, the overall smoking prevalence during 
pregnancy was 7%.65 In the United Kingdom, smoking prevalence during pregnancy 
were 57% in the mid-1960s,66 31-35% in the mid-1980s,66,67 and 12% in 2013/2014.68 
Internationally, socioeconomic differences in smoking prevalence among pregnant 
women are evident.61,65,67 A survey of 54 low- and middle-income countries found a 
pooled smoking prevalence among pregnant women spanning from 0.6% in the 
African region to 3.5% in the Western Pacific region in the years 2001 to 2012. In 
these low-and middle-income countries, population based estimates of smoking 
prevalence during pregnancy are lacking.69 Although tobacco use is currently low, 
these women represent a target for the multinational tobacco companies and one may 
fear an increase in smoking prevalence.69  
1.5 Validity of self-reported smoking habits in pregnancy 
Smoking during pregnancy is today widely recognized as a behaviour that may harm 
the unborn child. On the other hand, it has been shown that women who continue to 
smoke during pregnancy has a higher denial of risk than non-smokers.70 Potential 
negative consequences of the denormalization of tobacco use, creating a social 
stigma, include loss of self-esteem, feelings of guilt, defensiveness and resolving to 
continue smoking.71 The validity of self-reported smoking habits has been questioned, 
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based on a situation where a person is under medical or social disapproval.72,73 The 
self-reported smoking habits among pregnant women may therefore suffer from 
underreporting. More underreporting of smoking has been shown among pregnant 
women compared to non-pregnant women.74 The smoking variables in registries and 
health studies are often used as central exposures, not only for studies concerning the 
harm from cigarette use, but also in other exposure-outcome studies where 
controlling for smoking habits is needed. The smoking prevalence among pregnant 
women is also used in government strategic plans to construct targets for 
intervention, as well as a measure of how well the population is protected against the 
harm of tobacco.31,73  
Nicotine as a biomarker is specific to tobacco. However, it’s half-life is short 
(2-3 hours) and it is therefore not recommended for use as a biomarker.75 Cotinine, 
the main metabolite of nicotine, is highly specific for tobacco use, and has a longer 
half-life (16 hours) than nicotine. Measured in biologic fluids, it has therefore been 
widely used as a biomarker for tobacco exposure.75,76 To date, the smoking 
information in the Norwegian Medical Birth Registry has not been validated against a 
biomarker. Using cotinine levels in maternal and umbilical cord serum, Swedish birth 
registry data on self-reported smoking is shown to be a valid measure of in utero 
tobacco exposure.77  
The Norwegian Mother and Child Cohort (MoBa) study, a large, prospective 
pregnancy cohort, was set up aiming at capturing better exposure data than obtained 
in the Medical Birth Registry.78 With its vast data on exposure and adverse endpoints, 
MoBa represents a valuable source for studies disentangling the aetiological factors 
of diseases. In this setting it is important to understand the accuracy of the self-
reported smoking habits among the pregnant participants.  
1.6 Second-hand smoke 
Second-hand smoke exposure, sometimes called environmental tobacco smoke or 
passive smoking, is related to the level of smoking prevalence and to what extend 
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smoke-free indoor policies are implemented in a country.79 Although the health risks 
of second-hand smoke are well known today,79 evidence of the effect of second-hand 
smoke exposure on the fetus is more limited than for active smoking. Associations 
between environmental tobacco smoke and stillbirth (OR~1.2), reduced mean birth 
weight (by 30-60 grams) and congenital anomalies (OR~1.1) have been reported.79,80  
1.7 Fetal growth, birth weight and small for gestational age 
Birth weight is a much used variable in epidemiologic research. It is recorded 
precisely, often by law on birth certificates, it is free and available (for example on 
http://statistikkbank.fhi.no/mfr/), it is related to an infant’s survival, and it has been 
associated with adult health and disease (the latter is reviewed in a separate 
paragraph; “The fetal origins of adult disease” page 31).81 
Birth weight can be described as “the product of fetal growth rate and 
gestational length”.82 In large sample sizes the distribution of birth weights 
approaches a Gaussian distribution, characterized by an extended lower tail.  Three 
parameters are used to describe the distribution: The first two include the mean and 
the standard deviation (SD), which define the predominant Gaussian distribution. The 
predominant distribution covers 95-98% of all births. The tail, also called the residual 
distribution, is the third component used to describe the birth weight distribution and 
it contains the births that fall outside the predominant distribution. While the 
predominant distribution resembles the distribution of term births (≥37 gestational 
weeks), the births in the residual are almost all preterm. Although the births in the 
residual are few, they are important as they contain the smallest infants at the highest 
risks, and they represent a substantial proportion of all perinatal deaths.81,83,84 
The term “Intrauterine growth restriction” has been used to describe that 
expected fetal size is not reached at a given gestational age.85 The term has been 
modified83 and “Small for gestational age” (SGA) can be defined as babies with birth 
weight which falls within the lowest 10% of birth weights at any given gestational 
age, adjusted for various factors (such as infant sex , ethnicity and other factors).85 
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Also other percentiles (such as the 2.5th and 5th) have been used to define SGA, as 
well as two standard deviations below mean birthweight for gestational age.86,87 
Several factors may influence fetal growth, including environmental factors 
(smoking, medication), genetic factors, or causes linked to the mother (diseases, 
infections, weight, nulliparity), the placenta or the fetus (anomalies).86,88,89  
A previous study from the MBRN covering the period 1999-2002, found that 
smoking could explain 12% of the SGA cases.17 For babies exposed to maternal 
cigarette smoking, the birth weight distribution is shifted to the left, to lower weights, 
with approximately 200 grams for babies born at term,90 compared to unexposed 
babies.18,91 It is established that the main mechanism through which smoking impacts 
birth weight is by growth restriction, rather than shortening the gestational age.18 In 
addition to shifting the curve leftwards, the residual among exposed infants is also 
larger than among non-exposed infants.  The larger residual is a result of more very 
small preterm births among the exposed babies. An additional finding is that exposed 
infants have higher relative weight specific perinatal mortality than non-exposed 
babies. In comparison to smoke exposed babies, a leftward shift in the birth weight 
distribution has also been observed for babies born in Colorado, USA, where altitude 
was hypothesized to cause growth restriction. For these infants however, there was no 
increased residual distribution or perinatal mortality, compared to those born in the 
U.S. as a whole.18 It is a generally accepted assumption that there is a direct effect of 
smoking on mortality, which is not mediated through birth weight.91 The birth weight 
shift for the smoke exposed babies may or may not be a contributing cause of the 
increased mortality. Though the association between birth weight and infant mortality 
is one of the strongest associations seen in the field of epidemiology,90 it is debated 
whether birth weight has a direct effect on mortality, or if it is due to 
confounding.18,81,90,91 However, the shift in birth weight may serve as a marker for an 
exposure being hazardous to the fetus.83 The mortality of babies exposed to smoking 
is a classic example of the “Low birth weight paradox”, which describes how low 
birth weight babies of high-risk populations have lower mortality compared to low 
birth weight babies in low-risk populations.81  
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Size at birth represents the result of a process.92 Using SGA as a measure of 
intrauterine growth restriction calls to attention that not all small babies are growth 
restricted and some large babies are growth restricted. Factors which have an impact 
on fetal growth affect fetuses across the whole weight span. However, using SGA as 
a measure, it is possible to examine how an exposure (such as smoking) shifts the 
distribution of birth weights through restriction of fetal growth. As a consequence of 
this shift, more babies will fall below the defined tenth percentile definition of SGA. 
Hence, it is the general shift in distribution of birth weights rather than the specific 
growth restricted babies, that is detected using SGA as a measure.83 
1.8 Implications of focusing on smoking during pregnancy 
There are several reasons why it is important to focus on pregnant smoking women: 
Firstly, pregnancy is a golden opportunity to stop smoking.93 Women have several 
encounters with health professionals during their pregnancy. This is a unique 
opportunity for midwifes and doctors to communicate with smoking women and 
emphasize the dangers of smoking and to support quit attempts. The goal is to get 
women to quit smoking by the time they are pregnant without relapsing postpartum. 
Smokers who quit at ages 25-34 years have themselves survival curves that are close 
to never-smokers.94 Secondly, the fetus in utero benefits from not getting exposed to 
smoking.  Third, children that grow up with smoking parents are at bigger risks of 
starting to smoke, than children whose parents didn’t smoke. 95,96 Fourth, children of 
smoking mothers are at risk for exposure to second-hand smoke in their homes.97 
Fifth, there is already a social gradient related to the behaviour of smoking.44 By 
exposing their child to smoking in utero, the inequality is further passed on to the 
child by limiting the child’s chance of a healthy life (through the morbidity and 
mortality associated with exposure to smoking in utero).15  
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1.9 Theories on how tobacco smoke affect the fetus 
There is an abundancy of studies linking clinical outcomes to in utero exposure 
to tobacco smoke. However, the physiology behind many of these associations is not 
completely understood.  There are several plausible pathways described, such as fetal 
hypoxia, toxin exposure and alterations in fetal development and physiologic 
response. Nicotine can cross the placenta and gain access to and accumulate in fetal 
compartments through maternal circulation, fetal skin absorption or in utero 
swallowing of amniotic fluid.98,99 Nicotine has been proposed to only have a moderate 
impact on fetal growth, when compared to the larger contribution of the combination 
of nicotine and the combustion products in cigarette smoke.4 Users of snus have an 
increased risk of SGA offspring, although substantially lower than the risk observed 
for smokers.16  
Some of the constituents in cigarette smoke, including carbon monoxide and 
oxidizing chemicals (oxides of nitrogen and several free radicals), have been called 
“reproductive toxins” as they may contribute to reproductive toxicity. Carbon 
monoxide can interfere with the transport of oxygen from maternal hemoglobin 
through the placenta to fetal hemoglobin by displacing oxygen and impairing the 
release of oxygen from hemoglobin. Oxidizing chemicals may contribute to maternal 
and placental vasoconstriction and premature rupture of membranes.100   
 
Smoking during pregnancy has been reported to have an effect on placental 
anatomy and its function, through a reduction in the dimensions of the villous 
capillaries101 and through thickening of the villous membrane, which might be 
expected to restrain gas transfer to the fetus.102 However, others have found no 
significant changes in histopathological lesions in placentas comparing smokers and 
non-smokers, suggesting that mechanisms such as vasoconstriction might not be 
expressed histopathologically.103 Fetal circulatory adaptations (like umbilical artery 
resistance) is also suggested as a mechanism by which maternal smoking during 
pregnancy influences fetal growth.104 
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It does not appear to be one single contributor in cigarette smoke that is alone 
responsible for the adverse outcomes seen in pregnant smokers. There are several 
plausible mechanisms described with several chemicals causing reproductive harm, 
either additively or synergistically.100 Epigenetic mechanisms acting through several 
biological pathways have also been proposed as underlying mechanism through 
which maternal smoking may affect various outcomes. 105 
1.10 Smoking cessation efforts among pregnant women in 
Norway. 
“Any government that is seriously committed to improving health of its population 
must have a strategy for controlling the use of tobacco and reducing the number of 
people who smoke.” Chambers et al, BMJ 1991.106 
Norway has been a pioneer internationally on tobacco control policies, which 
have now existed for more than 40 years. In Norway, the treaty called “The World 
Health Organization’s (WHO) Framework Convention of Tobacco Control” (FCTC) 
entered into force in 2005. FCTC was the first global public health treaty. It provides 
a plan for national and global actions against the tobacco epidemic,107 and has been 
called a landmark achievement in public health.108 In a comparison to 30 European 
countries, Norway was in 2006 ranked as third by a Tobacco Control Scale, which 
sought to quantify the implementation of tobacco control policies.109 The scores were 
high for price, smoking restriction in public places and advertisement ban, but low for 
mass media campaigns and smoking cessation efforts.31 For the strategic period 2013-
2016, the Ministry of Health and Care Services aimed at having mass media 
campaigns directed at pregnant women in order to motivate tobacco use cessation.31 
In 2006, a mass media campaign against snus use during pregnancy was launched.110 
Smoking cessation during pregnancy is shown to reduce the risk of adverse 
harmful effects, including intrauterine growth restriction.34,111 In 1989, a national 
campaign focused on motivating women to stop smoking during pregnancy.52 In the 
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study years covered in the present thesis (from 1999 to 2014) information aiming 
specifically at pregnant women has included pamphlets delivered to mother-and-child 
clinics, health centres and general practitioners, training of health personnel in 
communication skills in motivational interviewing, and advertisement in magazines 
focusing on the positive aspects of staying smoke-free.112 National smoking cessation 
services have been available through a quit line (Røyketelefonen) which has evolved 
into a website, as well as social media site and a smartphone app (slutta.no). The 
national guidelines for smoking cessation recommend pregnant women to stop 
smoking without use of nicotine replacement therapy (NRT). However, NRT should 
be considered when pregnant women can’t stop smoking.113  
A decrease in smoking prevalence among pregnant women was reported 
before the decline in smoking prevalence among women in the general population.52 
This might imply that the focus put on pregnant women in 1989 and onwards 
contributed to the start of the decline, while the general devaluation of being a 
smoker as well as tobacco control policies for the population as a whole38,42 might 
have contributed to the further decline. However, in Denmark a decline in smoking 
among pregnant women were observed from 1989 without the presence of anti-
smoking campaigns directed at pregnant women.114 As the anti-smoking campaigns 
conducted by the Norwegian authorities approached women at an earlier point in the 
development of female smoking habits compared to the males’ development, it may 
have contributed to the lower level of tobacco consumption among women.40 
1.11 Tobacco transmittance across generations 
It has previously been shown that women with smoking parents more often smoke as 
adults.115 Whether maternal smoking during pregnancy has a causal relation to the 
offspring’s tobacco use, distinguished from the childhood social environmental as 
well as genetic factors, is debated.116,117 Studies of siblings discordant for maternal 
smoking during pregnancy have not shown any consistent link between maternal 
smoking and several measures of tobacco habits in offspring.118-121  While one study 
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found no association between exposure to maternal smoking and later tobacco 
dependence in the offspring,121 another study found maternal smoking to be 
associated with nicotine dependence in the offspring.120 Other sibling studies suggest 
that previously reported higher risks of tobacco use among offspring exposed to 
tobacco in utero are not causal, but confounded by familial background factors 
(genetic or environmental).118,119   
1.12 “The fetal origins of adult disease” hypothesis 
In the 1970s, the Norwegian physician Anders Forsdahl, presented a hypothesis 
linking poor living conditions in childhood and adolescence with later mortality from 
arteriosclerotic disease.122,123 However, a correlation with lung cancer in adulthood 
was also found and cigarette smoking was not excluded as a possible mediator for the 
correlation between infant mortality and arteriosclerotic heart disease.123 
In 1986, David Barker and Clive Osmond proposed poor nutrition in early life 
to account for their discovery of geographical differences in mortality from ischaemic 
heart disease (in 1968-1978) and the relation to past differences in infant mortality 
rates (in 1921-1925) in England and Wales.124 In 1989, David Barker and colleagues 
published that body weight at one year was associated with later death from ischemic 
heart disease among men born during 1911-1930 in Hertfordshire, England. For this 
population, weight in infancy and later death rates (during 1951-1987) were recorded. 
They found the highest mortality from ischemic heart disease among men with the 
lowest birth weight.125 Associations were also found between other anthropometric 
measures and coronary heart disease, as well as risk factors for coronary heart disease 
(blood pressure, serum lipids and impaired glucose tolerance).126-129 These 
associations made the foundation for “The Fetal Origins of Adult Disease” hypothesis 
(FOAD), proposing that the fetus in response to undernutrition goes through 
adaptions that persistently modify metabolism and organ structure.128 These processes 
acting at critical periods of fetal and early life when the system is plastic in contrast to 
the later fixed capacity, define the term “programming”.130 The hypothesis has also 
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been called the “Barker hypothesis”. Cardiovascular disease (CVD) and its risk 
factors were the initial outcomes studied. However, the hypothesis has gradually 
expanded to include a range of outcomes including chronic diseases such as asthma 
and obstructive lung disease, cancers, osteoporosis and mental disorders.130 In paper 
III, we focus on alternative explanations for the birth weight – CVD relation of the 
“Fetal Origins of Adult Disease” hypothesis.  
The concept of the “Fetal Origins of Adult Disease” hypothesis evolved into 
the “Developmental Origins of Health and Disease” (DOHaD) around the turn of the 
century, with more recognition of early life events following fetal life.131 Focus has 
also shifted to include factors not only predicting disease, but also well-being and 
health promotion.132 The association between birth weight and infant mortality has 
been suggested as non-causal, and further that caution should be made making 
assumptions on the causality between birth weight and adult diseases and 
mortality.81,133 It has been argued, however, that Barker and others did not consider 
birth weight on the causal pathway to disease, but rather as a proxy for unfavourable 
intrauterine factors.131 
Already in 1995, Paneth and Susser called upon findings taking maternal 
smoking into account.134 The early work from Barker and colleagues covers the 
period (from 1920 onwards) when cigarette smoking among women began and rose 
rapidly.135,136  
The controversy around the hypothesis has been expressed as the complexity 
of determining the relative impact of events in early life, versus that of later life such 
as environmental factors, on adult disease risk; namely which events have the greatest 
influence on health and which is potentially modifiable.131 Criticism has been made 
that the associations between fetal growth restriction and later disease may be 
confounded by a persisting adverse environment both in intrauterine life (causing 
poor intrauterine growth) and through childhood/adulthood (impacting lifestyle 
behaviour).135,137 These arguments have been countered by studies on birth weight and 
cardiovascular disease allowing for data on adult lifestyle, including smoking.138-140 
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Many claim that the associations between size at birth and risk of coronary heart 
disease are independent of adult life style.128,130,131 However, residual confounding 
cannot be excluded.  
It has been suggested that individual published studies of the association 
between birth size and later cardiovascular disease lack statistical power to be 
reliable, and that confounding control has varied, underlining the need for systematic 
reviews to carefully examine the evidence.141 Systematic reviews have found birth 
weight to be inversely associated with cardiovascular disease. Huxley et al, found a 
10-20% lower risk of ischemic heart disease per 1 kg higher birth weight.141 In a 
systematic review and meta-analysis of 22 studies, Risnes et al found a 12% lower 
risk for cardiovascular mortality per kg increase in birthweight (HR 0.88 (98% CI 
0.85, 0.91)).142 However, the authors acknowledge that controlling for confounding 
factors (such as smoking, socioeconomic status and gestational age) were limited in 
some studies.141,142 Though a consistent finding, Huxley et al question its impact for 
public health.141  A review by Skogen et al highlights how associations within the 
“Fetal Origin of Adult Disease” framework have unclear independent public health 
impact. The framework should rather complement an approach focused on genetic 
factors and adult lifestyle as causes of adult disease.143 The most recent review on 
birth weight and later cardiovascular disease describes evidence as highly suggestive, 
but not convincing, and finds weak evidence for birth weight to be an effective 




The overall objective was to study several aspects of smoking habits among pregnant 
women in Norway. Specific research aims were: 
1. To study changes and secular trends in smoking habits among Norwegian 
pregnant women in the period 1999-2004 and explore if there was a general 
decline in smoking in this group, or whether there were specific subgroups with 
differing trends.  
2. Underreporting of smoking among participants in epidemiologic studies may lead 
to validity problems, causing biased association measures. In order to study if 
self-reported tobacco use is a valid marker for tobacco exposure in the Norwegian 
Mother and Child Cohort Study (MoBa), we validated self-reported tobacco use in 
the mothers in a subsample of the MoBa against nicotine exposure assessed by 
maternal plasma cotinine.  
3. There are numerous publications describing the associations between being born 
with low birth weight and later disease, referred to as the “Fetal Origins of Adult 
Disease” hypothesis. The aim of the third study was to explore if women born 
with low birth weight more often end up as smokers in adulthood compared to 
women born with higher birth weight, and indirectly, if the “Fetal Origins of 
Adult Disease” hypothesis may partly be explained by residual smoking 
confounding.  
4. To estimate the risk of small for gestational age (SGA) in second pregnancy 
among women who stopped or started smoking from one pregnancy to the next, as 
well as among those who continued smoking through both pregnancies, compared 
to persistent non-smokers. Further, we wanted to explore if women who smoked 
in the first pregnancy without having an SGA infant and who continued to smoke 
in the second pregnancy were “protected” against growth restriction in the second 
pregnancy. 
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3. Material and Methods 
3.1 Datasources 
3.1.1 The Medical Birth Registry of Norway 
The Medical Birth Registry of Norway (MBRN) is a large, population based 
database, which has received compulsory notification of all births from at least 16 
gestational weeks since 1967 (from 12 gestational weeks since 2002, but with 
underreporting of the smallest fetuses).145-147 During pregnancy, a standard antenatal 
form is completed at visits to either a general practitioner or a midwife. The mother 
brings the form to the hospital when admitted for childbirth, and a midwife transfers 
information to the MBRN notification form. Additional information is included 
during the stay at the maternity department. The notification form contains 
information on demographic variables, the mothers’ health before and during 
pregnancy, complications and interventions during pregnancy and delivery, and 
pregnancy outcomes, as well as mothers’ national identification number and birth 
date of the child. The MBRN notification form was revised and extended in 
December 1998 and introduced checkboxes as the main way to notify data (Appendix 
A). Checkboxes have been shown to transfer more valid information to registries than 
written text.148 New information included maternal smoking habits at the beginning 
and at the end of pregnancy, folate- and multivitamin intake and medicines used in 
pregnancy, as well as ultrasound-based estimation of gestational age. Separate 
notification from the neonatal intensive care units for all infants transferred to such a 
unit after birth has also been mandatory since December 1998. From 2014 
information on maternal country of birth is available from the MBRN.  
Information on smoking habits is obtained through interview during antenatal care 
and noted on the women’s antenatal charts. This information, registered by 
checkboxes, is transferred to the MBRN notification form by a midwife at the time of 
delivery. In contrast to other information notified to the MBRN, women can refrain 
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from giving information on smoking habits. This may be one reason for the relatively 
large proportion of missing information for smoking habits. On the MBRN 
notification form there are checkboxes for non-smoking, occasional smoking and 
daily smoking as well as information about number of cigarettes smoked daily. A 
separate checkbox notifies that women refrain from giving smoking information. 
However, the use of this checkbox has not been optimal.146 In papers I, III and IV, the 
proportion of women missing information on smoking habits included both women 
refraining from giving information as well as those without any information on 
smoking habits.    
Most births (≥99%) in Norway take place in a hospital.32 The proportion of 
births that is captured by the MBRN is close to 100%.145 Valid information is 
essential for registry-based research and several variables have been validated in the 
MBRN.149-158 Birth weight and gestational age, variables which are related to the 
papers in the present thesis have been validated with satisfactory results.149 MBRN 
data was used for papers I-IV. 
3.1.2 The Norwegian Mother and Child Cohort Study 
The Norwegian Mother and Child Cohort Study (MoBa) is a population-based 
pregnancy observational study conducted by the Norwegian Institute of Public 
Health. 78,159,160 During 1999-2008 pregnant women were recruited by postal 
invitation together with the appointment for the ultrasound examination in gestational 
week 17-20. The participation rate was 41%.78 Institutions with >100 births per year 
were targeted. The recruitment started in Hordaland County in 1999 with a gradual 
expansion and became nationwide with 50 out of 52 hospitals with maternity units 
participating in 2005. At present, the cohort includes 114 000 children, 95 000 
mothers and 75 000 fathers.78 Biological material from mothers, fathers and children 
has been collected and stored in a bio bank. EDTA (Ethylene Diamine-Tetra-acetic 
Acid) whole blood was collected from both parents during pregnancy, as well as post-
partum from the mothers and from the child’s umbilical cord immediately after birth. 
Regular questionnaires collect information on general health, diet and environmental 
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exposures. Linkage to the child’s standard MBRN notification form is part of the 
MoBa database. Bias due to self-selection is shown to affect prevalence estimates for 
exposures and outcomes, but not exposure-outcome associations.161 For the purpose 
of paper II, we used the blood sample obtained from the mother at gestational week 
19 and the baseline questionnaire sent to the mother when she was about 15 
gestational weeks pregnant. 
3.1.3 Statistics Norway  
Statistics Norway has the general responsibility for official statistics in Norway. 
Statistics Norway provided information on mother’s country of birth, which was used 
in paper I. The National education database is also located at Statistics Norway. This 
register contains attained education for the Norwegian population on an individual 
level, and is updated annually with information on all residents 16 years or more. In 
this thesis, highest achieved education defined the educational level and was used in 
papers I, III and IV. Education was categorized as ≤10 years, 11-14 years and ≥ 15 
years in papers I and III and dichotomized as ≤10 years and ≥ 11 years in paper IV. 
3.1.4 The Cause of Death Registry 
Death certificates completed by a doctor are collected by the Cause of Death Registry 
and coded by the International Classification of Diseases (ICD) coding system. Since 
1925, Statistics Norway had the responsibility for the statistics on causes of death. 
From 2014, the Norwegian Institute of Public Health has had the full responsibility 
for the registry. The registry contains digitized records on causes of death from 
1951.162 Mothers’ in the first generation (G1, see Figure 5) causes of death were used 
in paper III. 
3.1.5 The National Registry 
The Directorate of Taxes is responsible for the National Registry. Live births are 
reported to this registry, where a national identification number is generated for each 
new born.147 The number consists of 11 digits, where the six first digits contain the 
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person’s date of birth. The three next digits represent an individual number where the 
third digit is gender specific, even numbers for women and odd numbers for men. 
The two last digits represent control digits. The national identification numbers of the 
child and the father as well as dates of death of mother, father or child are reported to 
the MBRN. For quality assurance, records in the MBRN are routinely matched 
against the National Registry. 
3.2 Study populations and design 
Paper I is a historical population based cohort study, with data collected 
prospectively by the MBRN. Data were obtained from the MBRN and Statistics 
Norway, including the National education database. The study population consisted 
of 259 573 Norwegian born women who gave birth from 1999 through April 2004 
(see Figure 4 for a flowchart with inclusions and exclusions for the study population). 
Exposures/explanatory variables were period (calendar years), maternal age, parity, 
marital status and education level. Outcome was smoking habits at the end of 
pregnancy. The proportion who quit smoking during pregnancy was a secondary 
outcome. 
Paper II is a validation study of a subsample from MoBa, a national 
prospective cohort study. A subsample of 3000 mothers was randomly selected from 
MoBa participants who had donated blood samples at the ultrasound examination, 
and who had births registered in the MBRN. Additionally, they had completed a 
baseline questionnaire as well as a food frequency questionnaire during the second 
trimester. Further details on the sampling process are described elsewhere.163 The 
participating women had given birth during the period July 2002 to December 2003. 
Three women were excluded because of missing plasma cotinine data, resulting in a 
study population of 2 997 women. In this validation study, measured plasma cotinine 





Figure 4. Overview of the study population in Paper I. 
Paper III is a historical population based cohort study, with data collected 
prospectively by the MBRN. We used data from the MBRN, the National education 
database and the Cause of Death Registry, and included 293 237 singleton women 
born 1967-1995. The birth records of these women (second generation; G2) were 
linked to their own first registered childbirth with available smoking habits between 
1999 and 2009 in a generational structure (Figure 5). Women registered in the MBRN 
with more than one birth in this period were thus only counted once. Information on 
smoking habits was missing for 29 168 (9.9%) women and these were excluded from 
the study population, as well as 3 837 (1.3%) occasional smokers and women whose 
birth weights were missing (n=306) or whose birth weights were less than 500 grams 
or more than 6000 grams (n = 6). A total of 11 918 (4.1%) women with missing 
gestational age were also excluded from the analyses. For absolute birth weight 
analyses, the focus was on women born at term (≥37 weeks) and for gestational week 
specific birth weight z-score analyses, 298 (<1%) women with absolute z-score 
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values equal to or above five were excluded. The women’s birth weight was the 
exposure and her smoking habits when she was pregnant 13-42 years later were the 
outcomes. The final study populations were 247 704 singleton women for birth 
weight z-score analyses and 238 488 term born singleton women for absolute birth 
weight analyses. 
In addition, we linked a total of 194 652 singleton men (G2, Figure 5) born 
1967-1994 to their own first registered infant delivered in 1999-2009. Inclusion 
criteria were available information on men’s birth weight and gestational age as well 
as partners’ smoking habits in their first pregnancy with registered smoking habits 
from 1999. The men’s birth weights were the exposures and his partner’s smoking 
habits in pregnancy were the outcomes.  
 
 
Figure 5. Overview of the study design in paper III. The figure depicts the first generation of 
mothers (G1), giving birth to sons and daughters in the second generation (G2), and the 
variables in focus in the main analyses in paper III.  
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Finally, for 222 808 women whose smoking habits at the end of the pregnancy 
were registered, we explored their mothers’ (G1) causes of death relative their 
daughters (G2) smoking habits. Data on causes of death were retrieved from the 
national Cause of Death Registry, 1969- 2009.  
Paper IV is a historical population based cohort study, with data collected 
prospectively by the MBRN. We used data from the MBRN and the National 
education database, and linked births to their mothers by means of the mothers’ 
unique national identification numbers to construct sibling structures, with the mother 
as the observation unit. A total of 118 355 Nordic born women giving birth to their 
first and second singleton infants during 1999 - 2014 were included in the study (see 
Figure 6 for a flowchart with inclusions and exclusions for the study population).  
To avoid misclassification of growth restriction due to constitution, women 
born outside the Nordic countries (Norway, Sweden, Denmark, Finland and Iceland) 
as well as women with unknown country of birth were excluded from the study 
population. In our material, women born outside the Nordic countries gave birth to 
babies whose birth weight were on average 119 grams less than babies born to Nordic 
women (t-test p<0.005). Further exclusions included 1803 (1.0%) women with 
missing information on birth weight, gestational age and sex of the second child, 5 
(<1%) women with negative inter-pregnancies intervals, and 204 (<1%) women who 
had late spontaneous abortions (<22 gestational weeks and birth weight <500 grams). 
Higher proportion of missing information for various variables in stillbirths and late 
spontaneous abortions is reported.152 122 479 women reported non-smoking or daily 
smoking at the end of the first two pregnancies. Women with missing information on 
smoking habits at the end in one of the pregnancies (n=50 089 women, 27%) or in 
both pregnancies (n=9 820, 5.3%), were excluded as well as women who reported 
occasional smoking at the end of pregnancies (n= 2 510, 1.4%).  
To look further into the smoking habits both early and late in the two 
successive pregnancies we divided non-smoking and daily smoking into nine 
smoking trajectories through the two pregnancies, excluding women whose smoking 
information was either missing at all registration points (n= 60 431, 33%), who were 
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occasional smokers at any registration points (n=5 805, 3.1%) or women who had 
unusual smoking trajectories (n=307, <1%). For these analyses we therefore had a 
study population of 118 355 women. 
Previous SGA due to any cause is a strong risk factor for recurrent SGA. In 
order to avoid mixing the effect of smoking with the effect associated with recurrent 
SGA due to other causes, additional analyses limited to women without SGA in the 
first pregnancy (n= 116 468 women) were done. Women who gave birth to an SGA 
baby in the first pregnancy (n=11 087) were analysed separately. Information on 
maternal education was only available for women giving birth in the period 1999-
2010 and this population consisted of 76 161 women (missing information: n=504, 
<1%). In this subset, we analysed the association between smoking trajectories as 
exposures and SGA in the second pregnancy as outcome while adjusting for or 





Figure 6. Flowchart over the population in paper IV. 
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3.3 Exposure variables, confounding variables/covariates 
In paper 1, all the covariates were obtained from the MBRN except maternal 
education and country of birth. These included parity (i.e. the number of previous 
births, para 0, para 1, para 2, para ≥3), maternal age in years (<20, 20-24, 25-29, 30-
34, ≥35), and marital status (married, cohabitant, single or other). Data for parity and 
maternal age was complete. The “other” category in marital status is a composite 
category including divorced/separated/widowed/other, as well as 1 057 (<1%) women 
with missing information. Maternal educational level was obtained from the National 
education database and contains the highest achieved education by year 2002. Data 
on educational level was missing for 581 (<1%) women. The study period from 1999 
to the first 4 months of 2004 were categorized into two groups; 1999-2001 and 2002-
2004.  In paper I, women born in Norway were included in the main analyses while 
women born outside Norway (n = 40 653) were analysed separately. The women born 
outside Norway were expected to differ in smoking prevalence compared to 
Norwegian-born women. Differences in smoking prevalence between the different 
counties of Norway were evaluated both with regards to smoking prevalence as well 
as the proportion with missing information on smoking habits. 
In paper II, the covariates obtained from the MBRN included parity (grouped 
as above), maternal age at delivery (<25, 25-34, ≥35) and marital status (as above). 
Data on parity, maternal age and marital status was missing for 10, 10 and 36 
participants, respectively. Information on prepregnancy body mass index (BMI) 
(<18.5, 18.5-24.9, 25.0-29.9, ≥30.0) and highest level of completed maternal 
education (≤12, 13-16, ≥17 years) were obtained from the MoBa baseline 
questionnaire and was missing for 116 (3.9%) and 77 (2.6%) participants, 
respectively. Self-reported nicotine exposure was obtained from the baseline 
questionnaire. Women could tick checkboxes if they smoked before or during the 
second trimester, if they were exposed to passive smoke at home or at work or both, 
and if they used chewing tobacco/snus, nicotine chewing gum, nicotine adhesive 
patch or nicotine inhaler. Snus use has not been registered for pregnant women in the 
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MBRN and has therefore not been available to study in the other 3 papers of this 
thesis. In paper II, a small number of women used snus according to MoBa.  
In paper III, all covariates except women’s (G2) and their mothers’ (G1) 
education was obtained from the MBRN. The main exposure was women’s (G2) own 
absolute birth weight and birth weight by gestational week z-score.164 Birth weight (in 
grams) is measured by the attending midwife immediately after birth. Ultrasound-
based estimation of gestational age was not available in the MBRN before 1999. In 
paper III, gestational age for the women (G2) was therefore based on the first day of 
the last menstrual period (LMP). 
Smoking primarily affects fetal growth in the third trimester in pregnancy.165 
We focused on women born at term (gestational week ≥37) when examining absolute 
birth weight, in order to avoid mixing reduced birth weight caused by preterm 
delivery with reduced birth weight caused by intrauterine growth restriction. 
Birthweight can be transferred to a z-score, which is defined as units of 
standard deviations from the mean.18 The z-score scale is based on the assumption 
that birth weights in groups being compared have an underlying Gaussian 
distribution. With this approach it is possible to compare groups with the same 
relative birth weights (relative to the Gaussian distribution of weight for the specific 
groups) rather than absolute birth weights.166 Z-scores for birth weight by gestational 
age were calculated by applying Norwegian birth weight by sex and gestational age 
standards,164 and were then categorized into 9 group from -4.99 to +4.99. The z-score 
category 0.50 to 1.49 was chosen as the reference group in all analyses.  
The women’s birth order was considered a potential confounding variable 
(first born, second born, third or later born) and was missing for 547 (<1%) women. 
The women’s year of birth was also considered as a potential confounding variable 
(1967-1976, 1977-1986 and 1987-1995). Other covariates used to describe the study 
population, were the women’s year of childbirth (categorized into 1999-2003 and 
2004-2009), and the women’s parity (grouped as before).  
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Highest achieved educational level for the women (G2) and their mothers (G1) 
was obtained from the National education database in 2009, and was grouped in 
three:  low (<11 years), medium (11-14 years) and high (college or university level: 
>14 years). For 348 (<1%) women (G2) and 907 (<1%) of their mothers (G1), 
information on education were missing. The mothers’ (G1) education was considered 
a potential confounding variable.  
Men’s (G2) birth weight was an additional exposure. Men with missing birth 
weight (n = 284, <1%), those with birth weight more than 6000 grams (n = 4), and 
those missing gestational age (n= 8 736, 4%) were excluded, leaving a study 
population of 194 652 men.  
In a sub analysis, the causes of death for women’s mothers (G1) were analysed 
in relation to the women’s (G2) smoking habits. Smoking habits will be further 
described under outcome variables. 
In paper IV, all variables except education were obtained from the MBRN. 
Smoking habits in two successive pregnancies was the main exposure variable. The 
covariates obtained from the MBRN included maternal age at delivery and marital 
status (both grouped as in paper I). Due to time trends in smoking habits and birth 
weight, year of first birth (1999-2007, 2008-2014) was considered a potential 
confounder for the association between smoking and SGA. Information on maternal 
education was available from the National education database for the period 1999-
2010. Adjustment/stratification for different levels of education (≤10 and ≥11years) 
when analysing the effect of smoking on SGA, was done in this subset. 
Gestational age was based on LMP. If the difference between LMP and 
ultrasound was >10 days or LMP was missing, gestational age was based on second 
trimester ultrasound measurements.  
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3.4 Outcome variables 
In paper I, the main outcome was smoking habits at the end of pregnancy, which was 
notified to the MBRN by three checkbox alternatives on the MBRN form: non-
smoking, occasional smoking and daily smoking. Smoking habits in the beginning of 
pregnancy were also used to evaluate the proportion of women quitting smoking 
during pregnancy. In a sub analysis we compared birth weight among non-smokers, 
daily smokers and non-responders. 
In paper II, the outcome was cotinine measured in plasma. Non-fasting blood 
samples in EDTA–tubes were collected from the women at the time of routine 
ultrasound appointment (median gestational week 18), centrifuged within 30 minutes, 
and placed in refrigerators. The samples were shipped by mail to the MoBa Biobank, 
where they were distributed onto polypropylene microtiter plates, at the day of 
reception (usually 1-2 days after sample donation), sealed with heat-sealing foil 
sheets and stored at – 80 degrees Celsius. Bevital AS analysed the samples. For 
plasma cotinine concentrations, a liquid chromatography tandem mass spectrometry 
method was used.167 Limit of detection for plasma cotinine was 1nmol/l (1.18ng/ml) 
and 111 women had concentrations below the limit. For these women values were 
imputed by giving each of them a random plasma cotinine value in the range 0-1 
nmol/l. For the sensitivity and specificity calculations, the main analyses included 
women reporting either daily smoking or non-smoking. In supplemental analyses 
women reporting occasional smokers were included. 
The metabolic clearance of nicotine and cotinine is shown to be markedly 
accelerated during pregnancy, with almost 50 % shorter half-life of cotinine than in 
non-pregnant state, resulting in a half -life of about 9 hours.168 A density plot of log 
plasma cotinine concentrations showed two distinct distributions. The lowest point 
between the two distributions were estimated using kernel density estimation and a 
bootstrap method (described under Statistical analyses), yielding a geometric mean of 
29.8nmol/l (95% CI 20.0, 56.0) which was used as a cut-off value to validate self-
reported daily smoking.  
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In paper III, the primary outcome was the association between own birth 
weight and adult smoking habits at the end of pregnancy. In addition, we studied the 
relation between a man’s birth weight and his female partner’s smoking habits at the 
end of her pregnancy. In further analysis, we looked at total mortality, death caused 
by cardiovascular disease and by lung cancer as outcomes for the mothers (G1). 
Cardiovascular disease was defined as deaths due to coronary heart disease and 
stroke, classified by The International Classification of Diseases (ICD): Version 8 
and 9: 410-414, 430-438, Version 10: G45, I20-I25, I60-65, I67, I69. Lung cancer 
was defined by ICD-8 and ICD-9: 162 and ICD-10: C33-C34. We also included one 
category called “Death from all other causes combined” which included all deaths 
except those from cardiovascular disease and lung cancer. 
In paper IV, the outcome was having an SGA infant in the second pregnancy. 
SGA was defined as birth weight by gestational age below the 10th percentile based 
on Norwegian birth weight by sex and gestational age standards.164 Additional 
analyses were done with SGA defined as birthweight below the 2.5th percentile.   
3.5 Statistical analysis 
Paper I: Statistical analyses were performed using SPSS (Statistical Package for the 
Social Sciences) version 12.0. Smoking habits were dichotomized into daily smoking 
and non-smoking. Occasional smokers were analysed separately. Crude odds ratios 
(OR) and relative risks (RR) with corresponding 95% confidence intervals (CI) were 
calculated from contingency tables, and represented changes in smoking prevalence 
during the study period. To estimate the effect of period, parity, maternal age, marital 
status and maternal education on women’s smoking habits, we used multiple logistic 
regression analysis with OR as the reported effect measure. To describe the 
variability of birth weight, we reported means and standard deviations (SD). For rare 
outcomes, ORs correspond well with RR estimates.169 Since logistic regression was 
used in paper I, and thereby adjusted ORs were the measures of association, the 
results could only be interpreted as RR estimates for the rare outcomes (for example 
smoking among highly educated women).  
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Paper II: Statistical analyses were performed using SPSS version 15, SAS 
(Statistical Analyses System) version 9.2 (SAS Institute, Cary, NC) and R version 
2.8.1 software (The R Foundation for Statistical Computing) for graphics. To get less 
skewed distribution of data, plasma cotinine concentrations were log-transformed and 
reported as geometric means, which is the antilog of means of the logarithmic 
values.170 The association between plasma cotinine and numbers of cigarettes smoked 
were estimated with Spearman’s correlation coefficient with 95% CIs. We used a 
nonparametric bootstrap method (the SURVEYSELECT procedure in SAS) to 
estimate the lowest point between two distinct distributions of log plasma cotinine in 
order to distinguish active smokers from passive smokers and non-smokers 
(dichotomized). By random resampling 10 000 times from the total population we 
made 10 000 alternative data sets. Kernel density estimation was used to find the 
lowest log plasma cotinine point between the two peaks in each set. The geometric 
mean was estimated from the 10 000 point estimates and defined the plasma cotinine 
cut-off separating active smokers and passive/non-smokers. By extracting the 2.5th 
percentile and 97.5th percentile from the 10 000 estimates, a corresponding 95 % CI 
was calculated. The bootstrap procedure was also used to calculate the overall 
sensitivity and specificity for self-reported daily smoking.  
Sensitivity and specificity describe the ability of a test to distinguish between 
individuals with and without disease. Sensitivity measures how well a test correctly 
identifies individuals with the disease, whereas specificity measures how well a test 
correctly identifies individuals without the disease. 171  
In paper II, the measured plasma cotinine cut-off was the “gold standard” and 
self-reported smoking habits was the “test”. Sensitivity was thus the proportion of 
women with plasma cotinine concentrations above the cut-off that were correctly 
identified by self-report as daily smokers. Specificity was the proportion of women 
with plasma cotinine concentrations below cut-off that were correctly identified by 
self-report as non-smokers (Table 2). 95% CIs for sensitivity and specificity were 
calculated using Wilson procedure without correction for continuity. 172  
 49
Table 2. Representation of self-reported smoking habits as the test and plasma cotinine 
concentration as the gold standard. 




≥30 nmol/l <30 nmol/l Total 
Self–reported  
smoking (test) 
Daily smoking a b a+b 
Nonsmoking c d c+d 
 
Total a+c b+d n 
                                       Sensitivity = a/(a+c)                Specificity = d/(b+d) 
 
Paper III: Statistical analyses were done using STATA, version 12.1 and IBM 
SPSS version 20. RR with 95% CI and p-values were calculated using generalised 
linear models for the binomial family in STATA with absolute birth weight and z-
scores for birth weight by gestational age as independent variables and dichotomized 
smoking status as the outcome. In this design, true confounders were factors that 
affected women’s birth weight (exposure) and the outcome (here women’s smoking 
habits when pregnant). We have therefore avoided adjusting for variables on the 
causal path between women’s own birth weight and her adult smoking habits, such as 
attained educational level. Variables that might be a common cause for both the 
women’s birth weight as well as the women’s own smoking habits were adjusted for 
and included educational level of women’s mothers’(G1), women’s (G2) year of birth 
and birth order. Birth order was included as a potential confounder as it is associated 
with both birth weight and adult smoking habits (first born siblings smoke less than 
 50
later born siblings).173 Cox proportional hazards models were used to analyse the 
hazard ratios for women’s mothers’ (G1) death by the women’s (G2) smoking habits 
at the end of pregnancy. We used a log-log survival plot to assess the proportionality 
assumption. Mothers’ (G1) age was the underlying time variable in the analysis, and 
mothers entered the follow-up at the year of their daughters’ (G2) birth. The analyses 
were adjusted for mothers’ (G1) education. 
Paper IV: Statistical analyses were performed using STATA, version 14.0 
Intercooled for Windows (StataCorp LP, College Station, Texas).  We used 
generalized linear models for the binominal family to calculate relative risks (RR) 
with 95% CIs for the association between smoking status in two pregnancies and risk 
of SGA in second pregnancy. Dichotomized smoking habits in the two pregnancies 
were categorized into 4 trajectories by smoking status at the end of two successive 
pregnancies: persistent non-smokers (No-No), quitters from first to second pregnancy 
(Daily-No), starters from first to second pregnancy (No-Daily) and persistent smokers 
(Daily-Daily).  Smoking habits early and late in the two successive pregnancies were 
then used to construct nine trajectories of smoking habits. Non-smokers throughout 
both pregnancies were considered the reference group. Confounders for the 
association between maternal smoking trajectories and a SGA baby in second 
pregnancy were considered after drawing causal diagrams (Figure 7)174, and included 
maternal age at first birth, marital status at first birth, year of first birth and maternal 
education. Directed Acyclic Graphs (DAGs) represent a type of causal diagrams, and 
are drawn by linking variables by arrows that represent causal effects.91 Maternal age, 
marital status, year of birth and maternal education may have effects on both smoking 
habits and SGA. Unknown factors represent unknown, common causes for SGA in 
both first and second pregnancy. Due to the addictive nature of tobacco, an arrow was 
drawn from smoking in first pregnancy to smoking in second pregnancy. No arrows 
were drawn from SGA in first pregnancy to smoking in second pregnancy as the data 
did not support that experiencing SGA was associated with a change in smoking 
habits in the second pregnancy.  
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Figure 7. Proposed Directed Acyclic Graph (DAG) for the causal pathway between smoking 
and SGA in 2
nd
 pregnancy. 
We used the 10th percentile of birth weight by gestational age to define SGA, 
however, we also included analyses based on the 2.5th percentile. Due to small 
numbers, this was not included in further analyses. To evaluate if smoking habits in 
two successive pregnancies were more closely associated with SGA babies in term 
pregnancies, separate analyses were done restricted to term born babies. This also 
excluded a possible selection bias linked to an increasing proportion of missing 
smoking habits at the end of pregnancy by decreasing gestational age: For term 
infants the proportion of missing smoking information at the end of pregnancy was 
18%, for infants born at 30 weeks this proportion was 25% and for infants born at 23 
weeks it was 41%.  
We explored if smoking trajectories had the same associations with SGA in 
second birth in different levels of maternal education in the subset of women giving 
birth in 1999-2010. We used two samples t-tests comparing group means (number of 
cigarettes smoked daily) to study the smoking dose in the different smoking 
categories. For these analyses we also split the study period in two as daily smoking 
has declined during the study period both among pregnant women (from 18 to 11% in 
1999-2004)175 and among women in the general female population (aged 25-34 years; 
from 32% to 13% from 1999 to 2014).39 
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Women who had missing information on smoking habits at any of the four 
time points of their two first pregnancies were grouped into different categories and 
their risk of SGA in the second pregnancy was examined using non-smoking women 
in both pregnancies as reference. 
 
3.6 Ethical considerations 
Necessary approvals were obtained from the Regional Committees for Medical and 
Health Research Ethics. Informed consent was obtained from each subject before 




4. Summary of main results 
4.1 Paper I 
In paper I, we had information on smoking habits at the end of pregnancy from 
224 409 (86%) of 259 573 Norwegian born women giving birth in the period 1999-
2004. We found a decrease in overall daily smoking prevalence among Norwegian 
pregnant women during the study period from 18% in 1999 to 11% in 2004 (RR 0.61 
(95% CI 0.58, 0.64)). When analysing characteristics related to changes in smoking 
habits, the study period was divided in two: 1999-2001 and 2002-2004. Both in crude 
and adjusted analyses a decline in smoking prevalence was observed from the first to 
the second study period in all women. Women with the highest parity and age as well 
as single women and women with low education had the smallest change in smoking 
prevalence between the two study periods. In a fully adjusted model, the odds ratio 
for being a daily smoker at the end of pregnancy increased with parity and with being 
unmarried. Maternal age did not seem to have an effect after adjustment, while 
maternal educational level was established as the most influential variable in the 
analysis. Factors pointing at which women quit and which continue smoking are 
important as they can be useful in intervention programs. 
We observed a higher prevalence of women quitting smoking during 
pregnancy in the second study period (32%) than in the first (23%) (RR 1.36 (95% CI 
1.32, 1.40)). The increase was observed for in all strata of studied sociodemographic 
variables. 
Cigarette consumption among daily smokers remained constant during the 
study period with 7.4 cigarettes per day. 
Nationally, there were large differences between counties in smoking 
prevalence at the end of pregnancy. The highest proportion of daily smokers was 
found in Finnmark (24%) and the lowest in Oslo (9.0%).  
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Occasional smoking during pregnancy decreased from the 1.9% to 1.4% from 
the first to the second study period. Both daily and occasional smoking was more 
frequent among women with low education. 
Smoking habits were available for 82% of women born outside Norway. These 
women had approximately half the smoking prevalence of women born in Norway. 
We observed a significant decline in daily smoking also among these women during 
the study period. 
The proportion of women with missing smoking habits at both the beginning 
and at the end of pregnancy increased during the study period from 11% to 13%. The 
highest proportions of women with missing smoking habits were found in Oslo (28%) 
and in Finnmark (19%). 
The mean birth weight of infants delivered to daily smoking women were 229 
grams lower than what was found for non-smokers, while it was 114 grams lower for 
women with missing information on smoking habits. Given that the reduction in the 
group with missing smoking information was due to maternal smoking, 
approximately half of these women could be daily smokers. Adding this proportion of 
estimated smokers gave a smoking prevalence of 20.2% in the first study period and 
17.9% in the second period.  
4.2 Paper II 
Among the 2 997 women in the MoBa subsample, daily smoking during pregnancy 
was reported by 263 (8.8%) women, and occasional smoking by 126 (4.2%) women. 
Ever smoking was reported by 1 491 (50%) women and 698 (23%) reported smoking 
daily the last 3 months prior to pregnancy. 472 (16%) women reported being exposed 
to passive smoking, either at work (n=216), at home (n=194) or both (n=62). Only 27 
women reported using smokeless nicotine products during pregnancy, 15 reported 
chewing tobacco or snus, 9 reported using nicotine chewing gum, 2 reported using 
nicotine inhaler and 1 used nicotine adhesive patches. 
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We found that plasma cotinine concentrations increased with increasing 
number of reported cigarettes smoked daily by daily smokers and weekly by 
occasional smokers. Passive smoking exposed non-smokers had low cotinine plasma 
concentrations (geometric mean less than 2 nmol/l), while women using smokeless 
nicotine products had plasma cotinine concentrations approximately at 100 nmol/l. 
In the validation analyses, occasional smokers, users of smokeless nicotine 
products as well as women with missing self-reported smoking habits were excluded. 
With plasma cotinine concentrations as the gold standard, a cut-off at 29.8 nmol/l 
(95% CI 20.0, 56.0), estimated from the study population, was used to calculate 
sensitivity and specificity of self-reported smoking habits. The overall mean 
sensitivity was 81.9% (95% CI 77.3, 86.4) and specificity was 99.4% (95% CI 99.1, 
99.7). We evaluated the uncertainty in sensitivity and specificity by using different 
cut-offs than the geometric mean (from 2.5th - 97.5th percentile), and this showed 
larger differences in percentile values for sensitivity (77.3-86.4%) than for specificity 
(99.1-99.7%).  
296 women in the study had cotinine values equal to or over the cut-off value 
(≥29.8nmol/l). Among these, 242 (82%) had reported daily smoking, while 54 (18%) 
had reported non-smoking. The 54 women who reported non-smoking, but were 
biochemically assessed as smokers, most often reported being ever smokers (n=45). 
More than half (n=30) reported daily smoking during the last 3 months prior to 
pregnancy and 13 reported being exposed to passive smoking.  
For the 121 women reporting occasional smoking (excluding those using 
smokeless nicotine products), 66% had cotinine levels above or equal to the cut-off 
value. For the 27 women reporting use of smokeless nicotine products during 
pregnancy, 11 reported daily or occasional smoking and 16 reported non-smoking, 
and a total of 21 women had plasma cotinine concentrations above or equal to the 
cut-off level. 
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Self-reported smoking habits were missing for 22 women (<1%).  Plasma 
cotinine concentrations were <1nmol/l for the majority of the women (n=13), 
<5nmol/l for 6 women and above the cut-off value for the last 3 women. 
4.3 Paper III 
In paper III, the association between birth weight and adult smoking was examined. 
There was an inverse trend between women’s own birth weight z-scores and 
prevalence of smoking in adulthood. Adjusting for women’s mothers’ (G1) 
education, women’s birth order and year of birth slightly weakened the results. 
Women with the lowest birth weight z-scores (-4.99, -3.51), had 80% increased risk 
of being a daily smoker in adult life, compared to women with birth weight z-score 
0.50-1.49 (RR 1.81 (95% CI 1.42, 2.31)).  
A similar trend between men’s (G2) birth weight z-scores and their partners’ 
adult smoking habits was found. For men in the two lowest birth weight z-score 
categories (-4.99, -3.51) and (-3.50, 2.51), the risk of having a smoking partner was 
about 40% increased compared to men with z-score 0.50-1.49. (RR 1.38 (95% CI 
0.94, 2.05)) and (RR 1.36 (95% CI 1.18, 1.57)). The lowest z-score category of men 
included only 21 partners.  
Results with absolute birth weight among women and men born at term showed 
similar results. Significantly increased risks of adult smoking were found for all birth 
weight categories lower than the reference group (4 000-4 499 grams), and with a 
dose-response relationship. 
Compared to mothers (G1) of non-smoking women (G2), the hazard ratios of 
cardiovascular death or death from lung cancer among mothers (G1) of smoking 
women (G2) were twofold: HR 2.1 (95 % CI 1.9, 2.3) and HR 2.3 (95% CI 2.1, 2.7), 
respectively. Death from other causes combined and death from any cause had a 
hazard ratio of 1.5 (95% CI 1.5, 1.6) and 1.7 (1.6, 1.7), respectively. Adjustment for 
the mothers’ (G1) education slightly attenuated the results; HR 1.8 (95 % CI 1.6, 2.0) 
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for cardiovascular death, HR 2.0 (95% CI 1.7, 2.2) for death from lung cancer, HR 
1.4 (95% CI 1.3, 1.5) for death for other cause and HR 1.5 (95% CI 1.4, 1.6) from 
death from any cause. 
4.4 Paper IV 
In paper IV, we studied the association between smoking trajectories across two 
successive pregnancies in the MBRN during 1999-2014 and the risk of SGA in the 
second pregnancy. First, smoking habits at the end of two successive pregnancies and 
the risk of SGA in second pregnancy were explored among 122 479 women. 
Compared to non-smokers at the end of both pregnancies, women registered as daily 
smokers in both pregnancies (persistent smokers) had a 2.9 fold increased risk (95% 
CI 2.7, 3.1) of SGA in second pregnancy, while women registered as daily smokers at 
the end of first pregnancy and non-smoker at the end of second pregnancy (quitters) 
had a 1.5 fold increased risk (95% CI 1.3, 1.7). Defining SGA below the 2.5th 
percentile resulted in similar RR estimates for quitters and higher RR estimates for 
persistent smokers. 
118 355 women had available smoking habits both at the beginning and at the 
end of two successive pregnancies. Women who smoked throughout the first 
pregnancy, but were non-smokers throughout their second pregnancy, had 30% 
increased risk of SGA in the second pregnancy (RR 1.3 (95% CI 1.1-1.6)). Women 
who smoked daily at the beginning of each pregnancy and quit smoking by the end of 
each pregnancy did not have increased risk of SGA in the second pregnancy. Women 
who smoked daily throughout their first pregnancy and at the beginning of the 
second, but had quit by the end of the second pregnancy, had a twofold risk of SGA 
in the second pregnancy (RR 2.0 (95% CI 1.6, 2.4)). Women who were non-smokers 
in the first pregnancy and smoked daily throughout their second pregnancy, had a 
80% increased risk of SGA in the second pregnancy (RR 1.8 (95% CI 1.4, 2.3)), 
although lower than for persistent smokers (RR 2.9 (95% CI 2.7, 3.1)). Restricting 
analyses to only term births in the second pregnancy resulted in similar relative risks 
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of SGA. Among women who did not experience SGA in their first pregnancy, 
persistent daily smokers had close to threefold increased risk of SGA in the second 
pregnancy (RR 2.7 (95% CI 2.5, 3.0)). When restricting analyses to women with 
recurrent SGA, the risk of SGA in second pregnancy was increased among persistent 
smokers (RR 1.8 (95% CI 1.6, 2.0)) but was lower than among women who did not 
experience SGA in first birth. However, women who experienced SGA in the first 
pregnancy had more than five times higher risk of a recurrent SGA in the second 
pregnancy, compared to women without SGA in the first pregnancy (RR 5.5 (95% CI 
5.2, 5.8)). The additional risk related to persistent smoking might therefore play a 
smaller role for SGA recurrence among these women than for women without SGA 
in the first pregnancy. 
Three of the smoking trajectories included daily smoking at the end of second 
pregnancy. The mean number of reported cigarettes smoked daily at the end of the 
second pregnancy was higher in the persistent smokers group (7.8 (95% CI 7.6, 7.9) 
in the Daily-Daily-Daily-Daily group) than in each of the two other groups (6.3 (95% 
CI 6.1, 6.6) in the Daily-No-Daily-Daily group and 5.8 (95% CI 5.5, 6.1) in the  No-
No-Daily-Daily group) (Two sample t-tests, P <0.05). The number of cigarettes was 
also higher in the Daily-No-Daily-Daily group than in the No-No-Daily-Daily group 
(P=0.01). This agrees well with the observed higher risk of SGA in the second 
pregnancy among persistent smokers. 
The strong association between persistent smoking and SGA in the second 
pregnancy was observed both among women with low and high education.  
The population of women with two successive singleton births in 1999-2014 
included a total of 184 898 women. Of these, 9 820 (5.3%) women had missing 
smoking information at the end of both pregnancies, and 50 089 (27%) women had 
missing smoking information at the end in one of the pregnancies. Women who were 
daily smokers in the first pregnancy and had missing smoking status in the second, 
had a doubled risk of SGA in the second pregnancy (RR 2.2 (95% CI 1.9, 2.6)) 
compared to persistent non-smokers. 
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5. Discussion 
5.1 Discussion of methods 
5.1.1 Study design 
Papers I, III and IV are all historical cohort studies, based on registries where 
information about the women, the births and the infants were registered 
prospectively. Paper II was a validation study based on a national, prospective cohort 
study.  The women giving birth were the study unit in cross sectional files in papers I 
and II. In Paper I, women could contribute with several births (51 751 (20%) women 
contributed with more than 1 birth), implying dependencies in data with slight 
reduction in standard errors. Dependencies can be accounted for by use of a cluster 
procedure in STATA (vce), estimating robust standard errors.176 We found only 
minimal changes to the confidence intervals. In Paper II, all the women were unique 
mothers, contributing with only one pregnancy to the study population. 
For paper III, the principal design spanned over two pregnancies and three 
generations, and was based on a generation-linked data file. Women in the first 
generation (G1) contributed with their first registered singleton pregnancy in the 
MBRN during 1967-1995. We studied the birth weight variation of daughters (G2) 
and sons (G2) and its relation to smoking habits of the daughters (G2 women) when 
they became pregnant, or the smoking habits of the son’s partner when she was 
pregnant (G2 partner). The offspring from these pregnancies (the third generation) 
was born during the years 1999-2009.  
Paper IV had a sibling design where our focus was the mother with her two 
first successive births. Since smoking has been registered since 1999, the study 
population was restricted to women with at least two singleton births born in the 
period 1999-2014. 
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A major strength of the papers I, III and IV is the use of population based, 
compulsory registries. The MBRN has compulsory registration of all births (≥16 
gestational weeks) in Norway. Through the national identification numbers, given to 
all individuals living in Norway, the registry is routinely linked with the National 
Registry. In the MBRN, several manual and computer based quality controls take 
place to solve inconsistencies and deal with registration errors.  
Paper II is based on the Norwegian Mother and Child Cohort Study (MoBa). 
With its prospective design, information on smoking habits is obtained before birth in 
gestational week 19. Since the participation rate is slightly above 40%, the study is 
not representative of the Norwegian population and not suited for prevalence studies. 
5.1.2 Precision 
Precision is high in the absence of random errors. Random error can be described as 
“…variability in the data that cannot be readily explained”.177 Options to reduce 
random error include increasing study size or modifying study designs in order to 
obtain information in the most efficient manner.178 The confidence intervals describe 
both the strength and the direction of the association studied. It also offers 
information on precision or the random variability of the point estimate.177,178 In 
papers I, III and IV, the study sizes were large, and in the main analyses the 
association measures were generally precise with narrow confidence intervals. For 
paper II, the study size was smaller and for subgroup analyses the confidence interval 




Internal validity refers to whether conclusions about causal relations in a study 
population are valid for the source population, or whether they may be affected by 
systemic errors. Three main categories of systemic errors can violate the internal 
validity: information bias, selection bias and confounding.178 
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Information bias (misclassification) 
Information bias or misclassification may cause error to the estimates if there are 
measurement errors in the information about the study participants, the exposures or 
the outcomes. In large registries, although quality controls are implemented, errors in 
registration of both exposures and outcomes may remain. Recall bias/differential 
misclassification is not likely in the papers in this thesis, since all information on 
exposures was gathered prospectively, before the outcome.  Nondifferential 
misclassification of the exposure occurs if exposure is misclassified independently of 
the outcome. Nondifferential misclassification of the outcome occurs if outcome is 
misclassified independently of the exposures of interest, or proxies for these.  
Nondifferential misclassification of a binary exposure or outcome may bias the effect 
estimates towards the null.178  
Women may change their smoking habits during pregnancy. 85% of the 
women in paper II had returned the questionnaire with self-reported smoking habits 
within 4 weeks of the timing of when the blood sample was taken. A recent Swedish 
study had a longer span between self-report and cotinine sampling. 77 A greater time 
span from self-reporting to cotinine sampling has the potential to misclassify women 
who quit smoking during pregnancy as smokers based on self-report. Participants in 
MoBa, as well as attending nurses, were informed that blood samples could be used 
for research, but not specifically tested for nicotine exposure. It is therefore not likely 
that information on intended purpose of the blood sample influenced the accuracy of 
self-reported smoking habits or led to changes in smoking status. 
Completeness of smoking information in the Medical Birth Registry of Norway  
Missing information on smoking habits in the MBRN is a challenge for the 
researchers and health authorities using the registry data. Information may be missing 
at random, or because smoking women feel stigmatized and do not want to inform 
about their smoking habits, or missing because situations around the birth made it less 
likely for the midwife to be able to register all the information requested. If the latter 
happens, that is of great concern when using these variables. In the MBRN data, the 
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proportion of women with missing information on smoking habits at the end of 
pregnancy decreased with advancing gestational age (Figure 8).  
 
Figure 8. Percentage of women with non-reported smoking habits at the end of 2
nd
 
pregnancy by gestational week, data from MBRN 1999-2014.  
 
However, not only adverse events at delivery matter for the registration of 
smoking habits. The maternity units play an important part. Ullevål hospital 
(Norway’s largest delivery unit) in Oslo has delivered around 12% of the birth 
notifications nationally.146 For several of the years from 1999 to 2014, approximately 
60% of women delivering at Ullevål hospital refrained from informing about 
smoking habits in pregnancy. When Ullevål hospital (merged into Oslo University 
Hospital from 2009 together with Rikshospitalet) changed their notification 
procedures from paper forms to an electronic system (Partus) in 2014, the proportion 
refraining from giving information on smoking habits decreased considerably (from 
67% to 16%).146 This also occurred after the MBRN had informed Ullevål about their 
high proportion of missing smoking information (Kari Klungsøyr, senior medical 
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of births delivered at Ullevål hospital with registered smoking habits subsequently 
increased from 34% in 2013 to 86% in 2015.32 However, at Rikshospitalet, the 
transition from an old (Obstetrix) to a new (Partus) electronic system, led to an 
increase in proportion of women refraining from giving information on smoking 
habits (from 0 to 14%).146 As these differences in reporting seem to be on a system 
level rather than an individual level, they may affect smokers and non-smokers in a 
similar way and thus not lead to differential misclassification. 
Among women born outside Norway, the proportion of women refraining 
from giving information on smoking habits is higher than among Norwegian born 
women. This suggests that also communication difficulties may play a role in 
registration of smoking habits.146 
In the following paragraphs, sensitivity analyses are presented for papers I, III 
and IV to examine the potential bias introduced by missing smoking information. 
Few women had missing smoking information in paper II and that paper is therefore 
less focused in this regard. 
In paper I, 53 082 (20%) women had missing information on smoking habits 
at the end of pregnancy. Among these, 17 918 women had missing information about 
smoking at the end of pregnancy, but reported non-smoking at the beginning of 
pregnancy. These women were counted as non-smokers at the end. For the remaining 
35 164 women missing smoking information at the end of pregnancy, a total of 
31 199 had missing information on smoking habits both at the beginning and at the 
end of pregnancy, 663 reported occasional smoking and 3 302 reported daily smoking 
at the beginning of the pregnancy. 
As mentioned above, Ullevål hospital in Oslo has had higher proportions of 
women with missing smoking information than other institutions. In paper I, women 
giving birth at Ullevål represented 6.5% of the study population (n=259 573 
Norwegian born women). Of these women, as much as 42% (n=7 119) had missing 
information on smoking habits. The women giving birth at Ullevål represented 23% 
of all the women with missing smoking information. The other hospitals in that area 
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such as Rikshospitalet and Aker had a prevalence of women with missing smoking 
habits of 15% and 6.8%, respectively. This is important to the interpretation of the 
smoking prevalence among pregnant women in Oslo, as well as the interpretation of 
the prevalence of women with missing smoking information. This difference in 
reporting of smoking habits between the hospitals suggests that the proportion of 
women with missing smoking information is not only influenced by the proportion of 
women who want to hide their actual smoking habits. The proportion of women with 
missing information on smoking is also influenced by which institution they give 
birth at, suggesting a more non-differential misclassification of smoking 
habits/missing smoking habits. 
In paper II, information on smoking habits were missing for only 22 women 
(<1%) and among these, 3 women had cotinine value above the cut-off, suggestive of 
daily smoking. The small number of women with missing information on smoking 
information suggests less possibility for bias.  
In paper III, 9.9% of the single born women had missing smoking information. 
The percentage of women with missing smoking information was lower in paper III 
than in paper I due to the different design. In paper III, women contributed with the 
first birth after 1999 when smoking habits were registered. If most of the women with 
missing smoking information were born to smoking mothers, one would expect a 
strong relation to low birth weight. We observed a weak association between the 
occurrence of low birth weight and missing smoking information in adulthood (RR 
1.1 (95% CI 1.0, 1.2)). In a sensitivity analysis, all women with missing smoking 
information were assigned as daily smokers and were added to the main analyses. 
The reclassification attenuated the results, but did not change the dose-response 
pattern between birth weight and adult smoking habits. 
In paper IV, for women with two successive pregnancies, 5.3% (n=9 820) had 
missing information on smoking habits at the end of both pregnancies and 27% 
(n=50 089) had missing information in one of the pregnancies. Information on 
smoking habits at the beginning and at the end of the two pregnancies (4 time points) 
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was missing for 33% of the study population. Figure 9 displays the relative risk of 
SGA in second pregnancy by missing smoking information. In this figure the 
presented trajectories include most of the women; 90% of the women with missing 
smoking information are presented (n= 54 728). The remaining women have 
trajectories which only a few women share (n=307), and 1 604 women have a mix of 
statuses of missing and occasional smoking. Of the 54 728 women in figure 9, 50 584 
women belong to the trajectories involving non-smoking and missing, while 4 144 
women belong to the trajectories involving daily smoking, non-smoking and missing. 
Women who were daily smokers in first pregnancy and had missing information in 
the in second pregnancy had twofold increased risk of SGA in second pregnancy 
compared to persistent non-smokers. Women who had missing smoking information 
on all 4 times points had only a weak association to SGA in second pregnancy: (RR 
1.2 (95% CI 1.1, 1.3)). For several of the categories, the estimate as well as the 
confidence interval is above 1. This indicates that our results for women with 
registered smoking habits are not much overestimated by missing information.  
For women who did not experience SGA in second pregnancy, 18% had 
missing smoking habits at the end of pregnancy. In comparison, the proportion was 
19% for those experiencing SGA in second pregnancy (RR 1.1 (95% CI 1.02, 1.1)). 




Figure 9. Trajectories including missing information on smoking habits and the adjusted 
relative risk of SGA (10
th
 percentile) in 2
nd
 pregnancy among Nordic born women with two 
successive singleton pregnancies 1999-2014. Persistent non-smokers serve as reference 
category. Analysis was adjusted for maternal age, marital status and year of first birth. 
Reprint from paper IV (supplemental material). 
 
Maternal Education 
We used attained education as a proxy for measuring socioeconomic status. In recent 
years, smoking and education are closely related. Obtaining information on education 
from Statistics Norway through record linkage should ensure minimal potential for 
differential misclassification in papers I, III, and IV, as smoking habits and education 
were collected from different sources. After defining the study populations, less than 
1% of women in paper I, III and IV had missing information on education (or their 
mothers’ education in paper III). In paper II, education was obtained from the MoBA 
questionnaire and was missing for 2.6%. Since only few women had missing 
information on education, the likelyhood of bias is minimal. 
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  In paper I, maternal education was the strongest predictor of smoking during 
pregnancy. In paper II, sensitivity of self-reported smoking was lowest in women 
with high education; however this group included few women. In paper III, adjusting 
for women’s mothers (G1) education slightly attenuated the results. In paper IV, 
stratifying on women with high and low education revealed a strong association 
between persistent smoking and SGA in second pregnancy in both groups. Therefore, 
the results changed little when education was used as an adjustment variable. 
Cotinine 
Cotinine was measured in a subsample of women in MoBa. In the study it was 
possible to exclude snus users, which is another source of nicotine reflected in 
cotinine measurements. Differences in nicotine metabolism may lead to 
misclassification of smoking women as non-smokers, based on their cotinine serum 
levels and the chosen cut-off value in paper II. Genetic polymorphisms of the 
CYP2A6 gene are associated with the variability in the nicotine clearance to cotinine 
and may give rise to inter-individual differences in nicotine metabolism.179 We 
evaluated the uncertainty of the chosen cut-off and found that the percentile values in 
sensitivity varied somewhat more (77.3-86.4%) than the values of specificity (99.1-
99.7) for different cut-offs.  
Parity 
In paper IV in the sibling analyses, we included women’s second birth that was 
registered in the MBRN. The sibling file is sorted by women’s successive 
pregnancies registered in the MBRN, and this succession was the basis for the 
analyses. This may in some instances not reflect a woman’s actual second pregnancy 
since early miscarriages are not registered in the MBRN, and are also quite 
frequent.180 
Gestational age 
Gestational age together with birth weight is the basis for z-score for birth weight by 
gestational week calculations and SGA. Only LMP based gestational age was 
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recorded in the MBRN until 1998, after which ultrasound based estimations were 
included in the registry. In both papers III and IV, gestational age was based LMP. In 
paper IV, if LMP was missing or there was a difference of more than 10 days 
between LMP and ultrasound based gestational ages, ultrasound based gestational age 
was used. Information on gestational age was missing for 4% in paper III and for 
<1% of second births in paper IV. Gestational age in the MBRN was missing for ~4% 
for the first ten registry years (1967-1978), and then gradually increased to ~10% in 
the 1990s. After 1999 less than 0.1% of births had missing gestational age. 
Gestational age could potentially be misclassified through uncertain last menstrual 
date, bleeding in early pregnancy mistaken for a period, or errors in registration.181  Z-
scores for birth weight by gestational week and SGA (birth weight below the 10th 
percentile) were computed by applying Norwegian birth weight standards based on 
data from the MBRN.164 Using this standard we could identify and exclude erroneous 
gestational ages given the birth weight, as birth weight is registered less erroneous 
than dates.164,181 In paper III, absolute z-score values of 5 or more were excluded. In 
paper IV, this exclusion was not done. However the number of women with second 
births with absolute z-score values of five or more were very few (n= 14) in the study 
population and the results did not change when these were excluded.  
Birth weight and small for gestational age 
Birth weight is a precise and more reliable measure than gestational age 
estimates.164,181 In papers III and IV, birth weight was missing for less than 0.5% of 
the study populations. In paper III, z-scores for birthweight by gestational week equal 
to or above an absolute value of five were excluded (n=298, <1%,) in order to 
eliminate those with likely misclassified gestational age. Analyses on associations 
between adult smoking habits and a person’s own absolute birth weight at term or z-
score for birth weight by gestational week resulted in similar patterns. In paper IV, 
SGA was defined as birth weight below the 10th percentile for gestational age and 
sex. To examine if a more strict definition of SGA would change the results, the 
analyses were repeated applying a definition of SGA below the 2.5th percentile. This 
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resulted in higher relative risks for persistent smokers and starters and similar risks 
for quitters. 
Cause of death 
The Cause of Death Registry has near complete coverage for medical information on 
all deaths. Quality control is done by linkage with the National Registry, and 
reminders are sent out to Chief Municipal Medical Officers for missing certificates.162  
The death certificate is completed by a doctor who may or may not know the dead 
person, depending on time and place of death. The most important issue in data 
quality is the frequent use of unspecific codes for underlying cause of death, 
reflecting terminal stage or complication rather than information on disease.162  
Confounding  
A structural definition of confounding is bias that occurs when there are common 
causes of the exposure and the outcome of interest (so-called open backdoor paths).182 
Providing first the definition of confounding; Hernan et al have defined a confounder 
as “any variable that can be used to help eliminate confounding.”182 
Confounders, and also surrogates of proper confounders, may be stratified on or 
adjusted for to block confounding paths, though with caution as to how closely the 
surrogate is associated with the actual confounder.178 In the studies included in the 
present thesis, confounders were identified a priori.  
In paper I, the change in smoking habits from first part of the study period 
(1999-2001) to the second part (2002-2004) was evaluated in strata of parity, 
maternal age, marital status and maternal education level. Within each stratum, we 
first only adjusted for period as the independent variable within each category, and 
then with period and all the other factors as independent variables. Full adjustments 
led to slight changes. To study which factors (of parity, maternal age, marital status, 
maternal education level and time period) was the most important for smoking at the 
end of pregnancy, fully adjusted analyses showed that low education resulted in the 
highest odds ratio for smoking at the end of pregnancy.  
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In paper II, the sensitivity and specificity for self-reported daily smoking was 
stratified on background variables; maternal age, parity, marital status, pre-pregnancy 
BMI, and maternal education. Women with high education had the lowest sensitivity 
(68%) of self-reported smoking habits. However, the number of self-reported 
smokers in this group was small and the 95% confidence interval was wide; 46%-
85%. 
In paper III, analyses were based on records of births in two successive 
generations. The main exposure was the offspring’s birth weight in the first birth 
record, including the first generation as mothers (GI) and the second generation as 
offspring (G2). These offspring served as mothers and fathers in the next set of birth 
records, and our focus was the maternal smoking status (G2, Figure 5). The 
association between the woman’s birth weight and later adult smoking habits were 
adjusted for her mothers’ (G1) educational level, the women’s (G2) birth order and 
year or birth. The adjustment did attenuate the results slightly, but the pattern 
remained similar to the unadjusted analyses. The analyses of the association between 
birth weight of men and their partners’ smoking habits were not adjusted since we did 
not identify any obvious common causes for men’s birth weight and the partners’ 
smoking habits in pregnancy. As the main aim was to study the association between 
men’s birth weight and partner’s smoking habits, we did not find adjustment for 
partner’s education appropriate (no confounder).   
For the association between women’s smoking habits and mother’s cause of 
death, the analyses using Cox proportional Hazards model, were adjusted for 
women’s mothers’ education. This somewhat weakened the results, but they 
remained significant.  
In paper IV, the following variables were considered as potential confounders 
for the association between maternal smoking trajectories and SGA in second 
pregnancy; maternal age at first birth, marital status at first birth, year of first birth 
and maternal education. Adjusting for maternal age, marital status, and year of first 
birth did not change the results. Education was only available for a subset of the study 
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population (births in 1999-2010), but for this subgroup, the results remained similar 
when adjusting for education as well. In order to examine if persistently smoking 
women who did not experience SGA in first pregnancy were “protected” against 
experiencing SGA in second pregnancy, analyses were restricted to women who did 
not experience SGA in first pregnancy. By conditioning on SGA in first pregnancy, a 
“backdoor path” may be opened through unmeasured factors (see DAG in Figure 6). 
These unmeasured factors may represent genetic factors causally related to SGA in 
first and second pregnancy, and opening this path might introduce bias.183  As the 
results did not change much, the amount of bias could not have been substantial.  
There will be unmeasured confounders for all our studied associations. In 
paper IV, a woman’s pre-pregnancy BMI might have been a relevant variable when 
studying the association between smoking in two pregnancies and the risk of SGA in 
the second pregnancy. However, as smoking can affect BMI, and BMI can affect risk 
of SGA, BMI would be an intermediate in this analysis. As the main interest was to 
study the total effect of smoking on SGA, adjusting for BMI may not be warranted. 
Being a smoker might be associated with other unhealthy behaviours that we were 
not able to measure. Other possible confounders include caffeine and alcohol intake 
during pregnancy.     
Effect-measure modification 
Effect-measure modification can be defined as the situation where the measured 
effect of one variable on another is different across strata of a third variable.178 In 
paper III, the association between birth weight and later adult smoking was assessed 
across different levels of women’s mothers (G1) education.  For women (G2) whose 
mothers (G1) had high education, those with birth weight z-scores ≤-2 had a RR of 
1.4 (95% CI 0.96, 2.05) of later being a smoker, compared to women with z- score 
≥0. Among women whose mothers had low education, the corresponding RR was 1.5 
(95% CI 1.3, 1.6). The relative risks estimates were not significantly different with 
overlapping confidence intervals, and we concluded that there was little effect 
medication by the mothers’ (G1) educational level. 
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Likewise, in order to examine if there were differences in hazard ratios for 
death of mothers by daughters smoking habits within the study period, the period was 
split into two; 1999-2003 and 2004-2009. The hazard ratios for the four causes of 
death categories were higher in second period than the first, but again, with 
overlapping confidence intervals. 
In paper IV, the association between persistent smoking and SGA in second 
pregnancy was examined in strata of maternal education. For women with low and 
high education, we observed similar estimates (RR 3.1 (95% CI 2.8, 3.6)) and (RR 
2.7 (95% CI 2.4, 3.1)), respectively. Little evidence of modification of education was 
observed as RR estimates were similar and confidence intervals overlapped. In this 
analysis we used non-smoking women with high education as the common reference. 
 
Selection bias 
Selection bias is bias that may distort results due to procedures related to selection of 
study subjects and from influencing factors relating to study participation. 178  
Paper I, III and IV are based on the MBRN which has national coverage of 
births and diminishes the possibility for selection bias. However, the design of paper 
III implies a cohort of women who have reproduced. To be included in the study, 
women must have been born in Norway after 1967 and have had at least one 
pregnancy from 1999 onwards. Women born outside Norway as well as women who 
did not reproduce are not included in the cohort. Being exposed to smoking in utero is 
associated with reduced fertility in the offspring.184 It might be that the babies most 
exposed to smoking and with the lowest birth weights did not contribute to the 
analyses. If these women had given birth, our estimates would most likely have been 
strengthened.   
Paper II, using MoBa data, is by design more vulnerable to selection bias than 
the studies from the MBRN. Women who agree to participate in a study may have 
different risk profiles than the total population, leaving the study participants with 
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different prevalence of risk factors than the total population. Self-selection bias may 
cause systematic errors in studies if an underlying factor both influences participation 
and some given outcome. The participation rate was slightly about 40% in the MoBa 
cohort.78 The questionnaires were in Norwegian, which by itself excluded women 
who were unable to read Norwegian. Young women, women living alone as well as 
mothers with more than two previous births were underrepresented, and the smoking 
prevalence was considerable lower in MoBa than in the MBRN.161 Also numbers of 
cigarettes smoked per day were lower in MoBa than in the MBRN and there were 
fewer women with unknown smoking habits. Also for pregnancy outcomes, there 
were differences between MoBa  participants and the total population. Despite 
differences in prevalence estimates of exposures and outcomes between participants 
in MoBa and women giving birth registered in the MBRN, the exposure-outcome 
measures were not biased in MoBa161. In paper II, 3 000 women were drawn 
randomly from the MoBa participants who had donated blood samples around week 
18 as well as having completed the baseline questionnaire and the food frequency 
questionnaire and who were registered in the MBRN. The population in the 
subsample has been described as being similar to the full MoBa cohort at the time the 
subsample was drawn.163 
 
External validity 
External validity refers to how well the results and conclusions drawn from a 
study may be generalized to the population outside the study.178 Internal validity is a 
prerequisite. The MBRN cover all births in Norway and in that sense the results in 
papers I, II and IV are applicable to women giving birth in Norway. Norway is in the 
fourth stage of the Tobacco Epidemic.35 Results may be less applicable to developed 
countries in different stages of the Tobacco Epidemic. The results in the descriptive 
cross-sectional aspect in paper I, the validity study in paper II, the generational aspect 
in paper III and the successive births aspect in paper IV are all tied to this model of 
the Tobacco Epidemic.  
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The women participating in MoBa may differ on some exposure and outcome 
variables from women giving birth in the general population.161 However, the well-
known study of British male doctors’ smoking habits and health, serves a prime 
example of a cohort study that was not representative of the general population, but 
contributed to new evidence on the hazards of tobacco smoking due to the selected 
cohort being homogeneous for confounders and behaviours.6 
The specific cotinine cut-off values used in one study should be used with 
caution in other populations. The sensitivity and specificity for a given cotinine cut-
off may vary with regions, with population characteristics and over time. With 
effective tobacco control efforts, the tobacco exposure for non-smokers should lessen 
and the distribution curve for serum cotinine should shift to the left towards non-
detectable levels. This has implications for the cut-off value which might be reduced 
compared to its level in times and regions with less tobacco control measures.185 
Although the results in paper II should be informative for the validation of self-
reported smoking habits in MoBa, this information is not necessarily applicable to the 
entire Norwegian pregnant population, as the proportion of smokers among women 
who agreed to participate in MoBa is lower than in the entire pregnant population.161 
However, recent results from the Swedish Medical Birth Registry,77 based on women 
who did not participate in any study, show high agreement between self-reported 
smoking habits and cotinine levels. These results lend support to the view that 
pregnant women in Norway and Sweden report their smoking habits fairly accurately.  
5.2 Discussion of main results 
5.2.1 Paper I 
In paper I, a decline in smoking prevalence at the end of pregnancy from 1999 to 
2004 was identified. The decline was evident in all subgroups studied, but of different 
magnitude. Decline in smoking prevalence among pregnant women in Norway has 
previously been described from the late 1980s to early 1990s,52,186 but this is the first 
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study that describes smoking data from the MBRN, with national coverage of all 
births in Norway. Maternal educational level was the most important explanatory 
variable for daily smoking at the end of pregnancy in adjusted logistic regression 
analyses. Occasional smoking at the end of pregnancy was more prevalent among 
women with low than high education. This was in contrast to what has been reported 
for women in the general population: In 2006, occasional smoking was most common 
among higher educated women. After 2009, this pattern among occasional smokers 
has changed, and women with high education have now the lowest occasional 
smoking prevalence.43  
In paper I, an independent samples t-test between smokers in the first and second 
study period showed no difference in mean cigarette consumption between the time 
periods. Mean number of cigarettes smoked daily in the first period was 7.43 (SD 
4.53), and 7.39 (SD 4.48) in the second period. This is consistent with a previous 
Danish study that found little change in mean number of cigarettes smoked daily 
during the years 1989-1996. 114 However, a previous study from a Norwegian county 
found a reduction in number of cigarettes smoked daily among pregnant women from 
1987-1994.52  
Women who continue to smoke in pregnancy more frequently have low 
income, low education and mental health problems.187-189 In paper I, we identified one 
third of teen mothers as daily smokers at the end of pregnancy. Young pregnant 
women may adjust less to tobacco policy measures than older pregnant women. This 
polarization in smoking habits by age among pregnant women was still evident ten 
years later.53  However, when adjusting for period, parity, marital status and maternal 
education level, it was evident that maternal age barely affected the odds of smoking. 
Maternal education was the most important factor for smoking habits in the adjusted 
analyses. In paper I, education was last updated in 2002. This means that some 
women might have attained higher education that was not available in our data. As a 
teen mother cannot have reached high education when she gives birth, her potential 
for later education might not have been captured in this study.  It might be that the 
potential for more education in these women drove the analyses so that maternal age 
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became the least important variable in the adjusted variables. Additional analyses 
done on the same material, but with education updated in 2009,  showed that among 
women who gave their first birth as teenagers, the smoking prevalence was 39 % 
among those not achieving higher education later (at 2009), compared to 14% among 
those achieving higher education.  To further explore how much “support” these teen 
mothers had, a generational approach was used: Among mothers (G1) with low 
education, their daughters (G2) who became teen mothers had a 30% daily smoking 
prevalence at the end of pregnancy, compared to an 18% smoking prevalence of 
pregnant teen mothers whose own mothers had high education. These analyses show 
that although there is high smoking prevalence among teen mothers, there is also 
socioeconomic heterogeneity within this group, associated with smoking prevalence.   
Smoking habits among pregnant women is a sensitive subject and women may 
underreport such behaviour. In the study population, 20% had missing smoking 
habits at the end of pregnancy and 12% had missing smoking habits both at the 
beginning and at the end of pregnancy. Among those with missing smoking habits at 
the end, about 1/3 were registered as non-smokers at the beginning of pregnancy and 
they were in our analyses counted as non-smokers throughout. In comparison, the 
Swedish Medical Birth Register have registered smoking habits in week 30-32 since 
1991, but due to the high proportion of missing data (67-89%) this variable has only 
been used for statistics since year 2000. However, smoking in the beginning of 
pregnancy has been registered since 1983. In 2005 and 2006 the proportion of 
pregnant women with missing smoking habits in week 30-32 were 15% and 9%, 
respectively. 190,191  
5.2.2 Paper II 
The Norwegian Mother and Child Cohort Study (MoBa) is a large population-based 
cohort study aiming at identifying causes of diseases.78 The validity of self-reported 
smoking habits in MoBa had not previously been described. Some studies have found 
the validity of self-reported smoking habits among pregnant women to be in good 
agreement with biomarkers,77,192-194 others have not,195-197 while others again just state 
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the amount of misclassified self-reported non-smokers.198 A smaller Swedish study 
found similar sensitivity and specificity for self-reported active smoking as we found 
in our study. However, they lacked information on occasional smoking. The 
misclassification on smoking habits was higher among women who reported recent 
smoking cessation.192 Similarly, in our study among the 54 self-reported non-smokers 
with plasma cotinine levels above cut off, 30 women reported daily smoking the last 
3 months before pregnancy. Consistent with others, we found a bimodal distribution 
of log plasma cotinine concentrations,76,199,200 suggestive of a distinction between 
active smokers and non-smokers/ passive smokers. We suggested a cut-off at 29.8 
nmol/L (5.3ng/ml) plasma cotinine after identifying this as the lowest point between 
the two distributions. Studies on non-pregnant populations have used higher serum 
cotinine cut off levels to identify active smokers: 80-85 nmol/L.199,201,202 Studies of 
pregnant women have used cut off levels in the range of 17 to 99 nmol/L (3-18 
ng/ml).73,74,193,194,198,203,204 For cord serum, similar cut-off values have been used (17-85 
nmol/L, 3-15 ng/ml).77,205 The lower range cut-off levels (17 nmol/l, 3 ng/ml), were 
used in the more recent studies.77,204 A cut-off level at 17 nmol/l (3 ng/ml) has been 
proposed as an overall cut-off for the U.S population, and 27 nmol/l (4.7 ng/ml) for 
non-Hispanic white women.76 However, a general cut-off value for pregnant women 
has not been established.  
The strengths of the study include the detailed available information on active 
smoking, occasional smoking, smokeless nicotine exposure and different sources of 
exposure to passive smoking (at home and at work), which is more detailed than 
other studies that miss either one or more of these exposures.77,192,198 There were few 
women with missing self-reported smoking habits (<1%) in the MoBa study sample.  
Negative predictive value (NPV) is described as “the proportions of patients 
with negative test results who are correctly diagnosed”,169 and might also be of 
interest in a validation study. Sensitivity and specificity is not affected by the 
prevalence of the disease of interest, however NPV depends on this prevalence. 
Additional analyses not included in paper II showed that negative predictive value 
(NPV) (in table 2: d/(c+d) was 2516/(2516+54) = 97.9%). A NPV of 98% means that 
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among women who were self-reported non-smokers, 2% had cotinine values 
suggesting daily smoking. 
Women who participate in a study where they agree to fill in several detailed 
questionnaires will likely differ from women in the general population, captured by 
the MBRN, with regards to a more accurate reporting of their smoking habits. There 
are several reasons as to why validity of self-reported smoking habits may differ 
across studies, for example differences in cut-off values, the setting in which self-
reported smoking habits was obtained (population based or a specific study) and the 
degree of stigma surrounding pregnant smokers. This highlights the importance of 
explicit examining the validity of self-reported smoking habits in MoBa.  
While the cotinine concentration in biological fluids such as plasma, salvia and 
urine is considered a good biomarker for current ongoing exposure to smoking, either 
as active smoking or second-hand smoke exposure, one of its limitations is that it 
does not measure long-term exposure. For studying long-term exposure, 
measurement of nicotine in hair or nails is an option.75 
5.2.3 Paper III 
The hypothesis of paper III was that women born with low birth weight more often 
end up being adult smokers than women born with higher birth weights, and this 
places them at increased risk of later cardiovascular disease. This hypothesis was 
based on an assumption of smoking habits being passed on from one generation to the 
next: thus daily smoking in the first generation could cause both low birth weight in 
the second generation and also daily smoking when these low birth weight babies 
grow up. Their daily smoking as adults will increase their risk of cardiovascular 
disease.  
The MBRN includes information on birth weight since 1967 and maternal 
smoking habits since 1999. The association between birth weight of women and 
smoking habits at the end of their own pregnancy 13-42 years later was studied.  
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In order to further examine this non-biological association, we also tried to 
evaluate whether men born with low birth weight more often grew up in a smoking 
environment. This was done by studying the association between birth weight of men 
and their partners’ smoking habits when pregnant. Since partners frequently share 
smoking habits,206 their partners’ smoking habits would serve as a proxy for the 
men’s own smoking habits. The association between men’s low birth weight and their 
partners’ daily smoking may indicate that parts of the well-known association 
between low birth weight and later cardiovascular disease could be confounded by 
cross-generational smoking habits.  
The ideal situation to test the hypothesis would be to have information on 
smoking habits in two generations. As smoking habits during pregnancy were not 
registered in the MBRN before 1999, it was not possible to study smoking habits in 
two generations directly. However, to explore whether women’s smoking habits were 
related to their mothers’ smoking habits, we studied the relation between women’s 
(G2) smoking in pregnancy and their mothers’ (G1) smoking-related deaths. We 
observed a twofold risk of dying from lung cancer and from cardiovascular disease 
among mothers (G1) of smoking women (G2) compared to mothers of non-smoking 
women.  
The difficulties in associating early life factors with adult disease has been 
problematized also by others who found accumulation of risk factors being strongly 
associated with social class at birth.207  In paper I, we discussed that there seems to be 
an increasing social polarisation among smoking pregnant women concerning 
education. In paper III, we show that women born with low birth weight more often 
smoke as adults, and interpret this as a result of women whose mothers smoke, more 
often “inherit” the habit of smoking. Others have also shown that smoking is a 
behaviour repeated by the next generation.184,207,208 While we found a strikingly 
similar pattern for women’s risk of smoking by her own birth weight and men’s risk 
of having a smoking partner by his own birth weight, others have found weaker 
associations between maternal smoking during pregnancy and sons’ later smoking 
habits than daughters’.209 The latter study was small, which may partly explain the 
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differing results. However, parental smoking behaviour is likely not the only 
determinant of adult smoking habits, and experiences of hardships during childhood 
are also shown to be a determinant of smoking status.210,211  
Smoking during pregnancy was in a review from 1987 acknowledged as the 
most important single factor for low birth weight in developed countries.86 In paper 
III, we showed a significant trend between decreasing birth weight and increasing 
smoking rates. Several studies have found no such association between birth weight 
and adult smoking habits.140,212,213 Two of these studies are from the UK and one has 
1 394 female study participants aged 60-79 years in 1999-2001,212 while the other has 
1 258 male participants aged 45-59 in 1973-1983. 213 The third study is from the U.S. 
and has 70 297 female participants aged 46-71 in 1992.140 The three studies together 
cover both sexes and cohorts born in the 1920s to 1940s. All the three studies are 
based on self-reported birth weights, which could potentially lead to misclassification 
of birth weights. While some have reported sufficient accuracy in self-reported birth 
weights,214 others have found lower sensitivity for self-reported birth weights among 
individuals whose birth weights were lower than among those with higher birth 
weights.208 In paper III, the women were born between 1967 and 1995. Although 
smoking was on the rise in both the UK136 and the U.S.215 in the 1920s and the 1940s, 
our study population consists of offspring of women whose birth cohorts reached the 
historically highest peak smoking prevalence around 1970. The cohorts of women 
born in 1940 - 1944 and 1945-1949 had a peak smoking prevalence at 52%, aged 25-
29 and 20-24 years respectively.40 Although these are not prevalences of smoking 
during pregnancy, it does indicate that women in paper III were born in a time when 
smoking among women in general was common. The Nurses’ Health study was the 
largest of the mentioned studies.140 This study population consisted merely of nurses 
which makes the study less generalizable than the study in paper III, which is 
population based. 
Several studies that have examined size at birth (or weight at one year216) and 
later cardiovascular disease state that the association remain after adjustment for 
smoking.128,140,212,213,216-218 However, the relationship has not been accounted for in 
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detail, and there may be residual confounding.  While some studies have obtained 
information on birth weight from self-report,140,212,213,217 other studies have no data on 
gestational age.128,212,217 With paper III, the aim was to elaborate on adult lifestyle as 
an important factor for the association between birth weight and later cardiovascular 
risk. In this study, it was possible to examine the relation between birth weight by 
gestational age z-scores and adult smoking habits in a large material. 
Publications on size in early life and later health outcomes have been criticized 
for failing to explore whether the measured effect is partly or wholly related to 
postnatal or prenatal factors, due to both misinterpretation of results as well as lack of 
using appropriate statistical models.219 Criticism has also been directed at studies 
supporting the “Fetal Origins of Adult Disease” (FOAD) hypothesis examining the 
relation between birth weight and adult blood pressure. Tu and colleagues have 
addressed how caution should be made when adjusting for variables that lie on the 
causal pathway between birth weight and adult blood pressure, such as adult body 
weight. Further, they have argued how failures to justify choice of confounders across 
studies make results difficult to compare.220,221 
A possible explanation for the observed associations between size at birth and 
adult cardiovascular disease is common genetic and/ or environmental factors that 
predispose to both low size at birth and adult cardiovascular disease.  The fetal 
insulin hypothesis suggests common genetic factors related to insulin resistance could 
lead to impaired fetal growth as well as insulin resistance and vascular disease in 
adulthood222. Support of this hypothesis has been shown with offspring’s size at birth 
being inversely related to both mothers’ and fathers’ cardiovascular mortality.223 
The work of David Barker and colleagues on FOAD, and subsequently 
DOHaD, has been characterized as a catalyst for life course thinking in 
epidemiology.224  Life course epidemiology has been defined by Kuh and Ben-
Shlomo as “the study of long-term biological, behaviour and psychosocial processes 
that link adult health and disease risk to physical or social exposures acting during 
gestation, childhood, adolescence, earlier in adult life or across generations”. This 
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definition was recently judged to have passed the test of time.224 The similarities 
between the approaches are the common interest in understanding how 
developmental factors are related to later health and disease. However, there are 
important differences. The DOHaD model sees chronic disease as result of an 
adaption to a fetal/early childhood life that turns into a maladaptation in adult life. 
Within life course epidemiology, survival into later life is considered a trait favoured 
in human societies, hence the “programming” appear too deterministic. Life course 
epidemiology has been interested in function; its maintenance or decline and the 
impact of factors acting across the lifespan. While life course epidemiology has 
aimed at examining timing of interventions, also in later life, in order to modify 
disease risk or change disease progression, DOHaD has been less interested in its 
potential beyond early life.224 Although differences between approaches, there is now 
a wish to “cross-fertilize”224 for future research.132 
5.2.4 Paper IV 
Smoking is an important risk factor not only for SGA,15,225 but also for morbidity of 
SGA infants.226 Reduced risk of SGA among women who quit smoking has 
previously been studied.16,34 However, while others have only looked at smoking 
habits at the beginning of each pregnancy,227 or just within one pregnancy,16,34 we had 
the opportunity to look at smoking habits both early and late in two successive 
pregnancies. A Swedish study using smoking information obtained during the first 
antenatal visit in two successive pregnancies, found an increase in birthweight in the 
second pregnancy among offspring of women who smoked in the first pregnancy, but 
not in the second.227 We found different risk patterns depending on the smoking 
trajectories throughout two successive pregnancies, and that smoking habits only at 
the beginning or only at the end of pregnancies did not sufficiently convey the risk 
for SGA in second pregnancy. Women who quit smoking before the end of second 
pregnancy had a lower risk increase than women who continued to smoke throughout 
her second pregnancy. Women who smoked daily throughout two pregnancies had an 
almost threefold risk of SGA in the second pregnancy, and this is in accordance with 
the previous study looking at SGA risk and smoking within one pregnancy.16 We 
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further found that women who smoked in both pregnancies, but did not experience 
SGA in the first pregnancy, were not “protected” against SGA in the second 
pregnancy. 
Comparing women with and without recurrent SGA in the first pregnancy, we 
concluded that the association between persistent smoking and SGA in second 
pregnancy was lower among women with recurrent SGA (RR 1.8 (95% CI 1.6, 2.0)) 
than among those whose first birth was not SGA (RR 2.7 (95% CI 2.5, 3.0)). 
However, women with recurrent SGA have a higher baseline risk for SGA (RR 5.5 
(95% CI 5.2, 5.8)), also among non-smokers. Using non-smoking women without 
SGA in the first pregnancy as the common reference group, we analysed the risk of 
SGA in second pregnancy by smoking trajectories: Non-smoking women with 
recurrent SGA had more than fivefold risk increase (RR 5.6 (95% CI 5.3, 6.0)), and 
persistent daily smokers with recurrent SGA more than nine fold risk increase (RR 
9.4 (95% CI 8.5, 10.5)). Although the RRs were higher among women with recurrent 
SGA, the increase in RR from non-smokers to persistent smokers did not exceed the 
increase from non-smoking to persistent smoking women among women without 
recurrent SGA. 
Some of the analyses on women with available smoking habits at the end of 
the two pregnancies were repeated after defining SGA by the 2.5th percentile. This led 
to higher RR estimates among persistent smokers (Daily-Daily) and starters (No-
Daily). 
Although we lacked information on maternal height and pre-pregnancy weight, 
it was possible to adjust for several other potential confounders; however these did 
not lead to great changes in the estimates, and indicates that unmeasured confounding 
is probably not a large threat to our conclusions.  
We found that quitting smoking reduced the risk of SGA. However, among 
women who smoked throughout the first pregnancy, but were non-smokers in the 
second pregnancy; we did observe a modest, but statistically significant 20% 
increased risk of SGA in second pregnancy. This observation calls into question 
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whether smoking in a previous pregnancy truly affects the growth conditions for the 
fetus in the next pregnancy. Although we cannot rule out changes in maternal 
cardiovascular status which in turn could affect fetal growth conditions, the women 
who have reported smoking through one pregnancy might be different from persistent 
non-smokers concerning the accuracy of reporting smoking habits, health 
consciousness or other health related behaviours. In paper II, we found that among 
the 54 women who reported non-smoking, but had cotinine levels above cut off, 45 
women were ever-smokers and 30 women reported being daily smokers the last 3 
months prior to pregnancy.  
 85
6. Conclusions 
We observed a considerable decline in smoking during pregnancy among Norwegian 
women in the period 1999-2004. The decline was evident in all subgroups, but the 
magnitude differed, especially in strata of maternal educational level. 
Using a subsample of nearly 3,000 women in The Norwegian Mother and 
Child Cohort Study with maternal plasma cotinine measurements, we found that self-
reported tobacco status in pregnancy had a sensitivity of 82% and specificity of 99%.  
The findings suggest that self-reported smoking status is a valid marker for tobacco 
exposure in the MoBa cohort. 
The birth weight of women born in 1967-1995 was associated with the 
women’s own smoking habits at the end of their first registered pregnancy in 1999-
2009, with more daily smokers among women with lower birth weights. The birth 
weight of men was associated with their partners’ smoking habits at the end of their 
first registered pregnancy in 1999-2009 in the same way. We further found that 
mothers of smoking women had higher risks of dying from lung cancer and from 
cardiovascular disease compared to mothers of non-smoking women. The indications 
of shared smoking environment through generations could have implications for the 
established association between birth weight and later cardiovascular disease.   The 
findings may add to the discussion of what impact early life factors have for later 
disease. 
Quitting smoking reduced the risk of SGA in second pregnancy. Compared to 
persistent smokers, the risk of SGA in the second pregnancy was reduced even 
among women who smoked in two pregnancies, but quit smoking before the end of 
the second pregnancy. Persistent daily smokers throughout two pregnancies had a 
higher risk of SGA in second pregnancy than women who smoked daily only in the 
second pregnancy. Women who smoked throughout both pregnancies and had not 
experienced SGA in the first pregnancy were not “protected” against SGA in the 
second pregnancy.  
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7. Future impliactions 
Although a decline in smoking during pregnancy has been documented, some fetuses 
are still exposed to tobacco smoke. This emphasizes the continued importance of 
striving for a tobacco-free future, as aimed at by the Norwegian government.31 
Addressing health inequalities should start at the beginning of life.228 
The first paper, the prevalence study of maternal smoking during pregnancy 
should warrant greater efforts to make pregnant women stop smoking and to 
encourage a greater focus on smoking cessation among fertile women. Tobacco 
control policies have not lead to the same reduction in smoking during pregnancy 
among all demographic groups. In 2013/2014, ten years after the last period in paper 
1 (2004), 21 % of women with low education smoked daily at the beginning of the 
pregnancy compared to 2% among women with high education.55 The tobacco-free 
future31 is not yet for all new-borns and efforts on tobacco control should continue. 
The second paper infers that the smoking variable can be used in the 
Norwegian Mother and Child Cohort Study for confounder control for smoking in 
future studies based on women in the cohort. 
The third paper warrants a more cautious attitude in proposing causal 
associations between birth weight and later disease in adulthood.  
The benefits of quitting smoking during pregnancy should be highlighted for 
every pregnant woman. Although stigma on a societal level could certainly contribute 
to lower smoking prevalence in the general population, there is a potential for 
negative consequences for some, making smoking cessation more difficult through 
loss of self-esteem, guilt and defensiveness.71 In patient meetings, consideration of 
lifestyle choices should be discussed with respect and empathy. The addictive nature 
of nicotine should not be a resting pillow, but should motivate and emphasize for 
health personnel the importance to support quit attempts among smoking pregnant 
women. 
 87
Norway is a rich country and its citizens as a whole do not face challenges of 
unclean water, scarcity of food or lack of shelter. However, the social gradient acting 
throughout the life of a human being, from early childhood, through adolescent health 
and school performances, through employment and adult health gives rise to 
inequality in health. The social gradient in health should inspire to a quest for the 
causes of inequalities as well as policies to enhance healthy lifestyle choices.228 
With the knowledge gained during the tobacco epidemic in developed 
countries, the opportunity to avoid the epidemic in low- and middle income countries 
should be seized. WHO have stated that if countries continue the tobacco control 
activities at current strength, the decline in smoking prevalence in low- and middle-
income countries by 2030 will be slower than in high-income countries. The male 
smoking prevalence in high-income countries will decline to around 20%, while 
middle-income countries will have a constant high male smoking prevalence of above 
30%. For women the smoking prevalence is predicted to fall below 15% in high–
income countries, and remain under 5% in low- and middle-income countries.2 The 
end of the tobacco epidemic has not yet been reached. There has been progress in 
implementing smoke-free legislation worldwide, and by now almost two thirds of the 
world’s population are covered by at least one best-practice-level tobacco control 
measure. However, in 2016 only 20% of the world’s population were covered by 
laws to protect people from tobacco smoke.2  
What is the way forward? The need for “tailored approaches” to combat the 
epidemic in locations with different patterns of tobacco use and understanding what 
works in different contexts and subgroups have been called upon.8 With 7 million 
deaths annually worldwide due to tobacco–related diseases (most due to smoking 
tobacco8), WHO suggest implementing its Framework Convention on Tobacco 




Paper I; table II, the 95% CI for OR1 for “Maternal age 25-29” should be (1.02,1.08) 
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Smoking during pregnancy from 1999 to 2004: a study from the
Medical Birth Registry of Norway
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Abstract
Background. The aims of the study were to describe changes in smoking habits and evaluate secular trends among all
Norwegian pregnant women during the period 19992004. We wanted to investigate whether there was a general decline in
smoking habits among pregnant women. We also wanted to identify population subgroups with diverging trends. Methods.
The Medical Birth Registry of Norway (MBR) has national coverage of all births of 16 or more gestational weeks. Since
1999, women have been asked about tobacco smoking at the beginning and at the end of pregnancy. We included records
from 304,905 women giving birth in the period January 1999 through April 2004. Women born outside Norway were
handled separately. The selection left a dataset containing 259,573 Norwegian-born women. Results. We obtained
information on smoking habits from 86% at the end of pregnancy. Among those, the daily smoking prevalence was reduced
from 17.3% in 19992001 to 13.2% in 20022004. Higher smoking prevalence was found among multiparous (3),
teenage mothers, single women, and women with low educational level. Conclusions. From 1999 to 2004, a substantial
decline in smoking prevalence among Norwegian pregnant women was identified in all subgroups. However, an increasing
social polarisation with regard to education and smoking habits was observed in the study period. In order to reduce the
smoking-related risks for unsuccessful pregnancy outcome, special attention should be paid to smoking habits among
multiparous, teenage women, single women and women with low education.
Key words: Smoking, pregnancy, secular trends, sociodemographic variables
Abbreviations: RR: relative risk, CI: confidence intervals, SD: standard deviation
During the last 10 years, the prevalence of smoking
among women has decreased in most developed
countries (1). In Norway, a substantial fall in every-
day smoking has been documented. In 2006, equal
proportions of daily smokers were found among men
and women. The smoking prevalence among women
aged 1624, 2534 and 3544 was 22, 20 and 28%,
respectively (2).
Smoking habits among pregnant women in the
Nordic countries have also changed markedly over
the last 20 years. In 1987, 34% of Norwegian
pregnant women were everyday smokers compared
to 22% in 1994 (3). In Sweden, smoking in early
pregnancy has declined by 1% annually over the last
20 years, and in 2002 the smoking prevalence was
11% (4). In Denmark, the proportion of smokers at
16 weeks’ gestation decreased from 34% in 1989 to
21% in 1996 (5).
The aims of this study were to describe changes in
smoking habits and evaluate secular trends among
all Norwegian pregnant women during the period
19992004. We wanted to investigate whether there
was a general decline in smoking habits among
pregnant women. We also wanted to identify popu-
lation subgroups with diverging trends.
Material and methods
We used data from the Medical Birth Registry of
Norway (MBR), which has national coverage of all
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births after 16 or more gestational weeks. Midwives
or physicians complete standardised forms for the
MBR, a mandatory procedure that has existed since
1967. The notification form is completed by inter-
viewing the women and using their hospital medical
charts. Data from the MBR provide information on
the woman’s obstetric history, age and marital status.
Since 1999, registration of smoking habits during
pregnancy has been included in the standardised
notification form and reported to the MBR. Women
are asked if they smoked at the beginning and/or
at the end of the pregnancy, to which they can
answer ‘no’, ‘occasionally’ or ‘daily’, and report the
‘number of cigarettes daily’ or they can decline to
answer. Smoking status was coded as a dichotomous
variable with the classification non-smoker or daily
smoker. Women who reported smoking occasionally
were handled in separate analyses. Information on
smoking habits at the beginning and at the end of the
pregnancy was available from 226,877 (87%) and
206,491 (80%) women, respectively. Among women
who were non-smokers at the beginning of preg-
nancy, data on smoking habits at the end of
pregnancy were missing for 17,918. They were
classified as non-smokers also at the end of the
pregnancy. Therefore, we recognised information on
smoking habits at the end of pregnancy from
224,409 women (86%). By comparing the birth
weight of babies of non-smokers, daily smokers and
non-responders, we estimated the number of daily
smokers in the non-responder group.
We included records from all births in Norway
during the years 19992003, and for the first 4
months of 2004 (n304,905). We dichotomised the
study period into period 1 (19992001) and period 2
(20022004).
Women born outside Norway were not included in
the main analysis and were handled separately.
Birthplace outside of Norway was recorded in
40,653 women, and was unknown for 4,679. The
selection left a dataset containing 259,573 Norwe-
gian-born women.
Smoking habits in the general population and
educational level was retrieved from Statistics Nor-
way. Educational level was categorised into elemen-
tary school (510 years), high school (1114 years)
and university (]15 years), according to the highest
completed education.
Statistical analyses were carried out with Statistical
Package for the Social Sciences (SPSS) 12.0. Multi-
ple logistic regression analysis was performed to
estimate the effect of the following variables on
smoking habits: period, parity, maternal age, marital
status and maternal education level. In order to
perform covariate adjustments, odds ratio (OR) were
used. The results are presented as relative risks (RR),
OR and adjusted OR with 95% confidence intervals
(CI). The RR represents changes in smoking pre-
valence during the study period.
Results
A general trend of decreased smoking prevalence
during the study period was observed. Pregnant
women were about half as likely as women in the
general population to be daily smokers. Daily smok-
ing among the general population decreased from
33% in 1999 to 23% in 2004 (RR0.70 (95% CI:
0.670.72)), while among pregnant women, a
greater decline in smoking prevalence was observed,
from 18% in 1999 to 11% in 2004 (RR0.61 (95%
CI: 0.580.64)) (Figure 1).
Based on reported smoking habits, daily smoking
at the end of pregnancy was 17.3% in the first
period and 13.2% in the second period (Table I).
The adjusted OR for parity showed small differ-
ences. Maternal age did not seem to affect the
adjusted OR, except for the oldest women. Single
women had a smaller decline in smoking preva-
lence during the study period than other categories
of marital status. The greatest differences were
found among women with different education
levels. Women with elementary school only had a
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Percentage daily smoking
women in the general 
population
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Percentage daily smoking 
women
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Figure 1. Smoking habits among women in the general population and pregnant women in Norway (19992004).



































































period to the second period, while university-
educated women had a 40% reduction.
Sociodemographic variables and daily smoking
at the end of pregnancy are presented in Table II.
The daily smoking prevalence at the end of preg-
nancy increased with parity. Women with 3 or more
previous births had almost twice the smoking pre-
valence of nulliparous. Smoking prevalence de-
creased with maternal age, except for women aged
35 years or more. Single women had about 4 times
the smoking prevalence of married women. Women
with elementary school only had about 8 times the
smoking prevalence of university-educated women.
The OR for smoking at the end of pregnancy,
adjusted for period and sociodemographic variables,
increased with parity, while maternal age did not
affect the risk for smoking when adjusted for other
variables. Adjusted OR also established education as
most influential for smoking during pregnancy.
More daily smokers quit smoking during preg-
nancy in the second period (31.8%) compared to
the first period (23.4%) (Table III). Quitting
smoking was defined as being daily smoker at the
beginning of the pregnancy and non-smoker at the
end of the pregnancy. Among those who remained
daily smokers, cigarette consumption was constant
during the study period (7.4 cigarettes per day).
Cigarette consumption increased with rising mater-
nal age and parity, and fell with maternal education
level.
Occasional smoking was reported by 3,240 (1.7%)
at the end of pregnancy. The prevalence of occa-
sional smokers at the end of pregnancy decreased
from 1.9% in the first period to 1.4% in the second
period. Women with elementary school only had a
higher prevalence of occasional smoking at the end
of pregnancy compared to university-educated wo-
men.
For women born outside Norway (n40,653), we
had information on smoking habits from 82%.
These women had half the smoking prevalence of
Norwegian-born women. Women aged 19 years or
younger and single women had a higher proportion
of smokers. Parity and education did not have as
strong effect on smoking habits as for Norwegian-
born mothers. In addition, among these women,
smoking prevalence was reduced during the study
period.
Table I. Smoking habits during pregnancy from 1999 to 2004 in relation to sociodemographic variables.
19992001 20022004
ntotal$ %smokers ntotal$ %smokers RR$$ 95% CI OR1* 95% CI OR2** 95% CI
Parity
0 52,088 15.3 36,257 11.9 0.78 0.750.89 0.75 0.720.78 0.74 0.710.77
1 46,509 17.0 34,052 12.6 0.74 0.720.77 0.71 0.680.74 0.75 0.720.79
2 22,621 19.8 15,471 14.7 0.74 0.710.78 0.70 0.660.74 0.73 0.680.77
3 8,520 25.2 5,651 20.9 0.83 0.780.88 0.79 0.720.85 0.80 0.730.87
Maternal age
B20 3,260 33.0 2,092 29.9 0.90 0.830.98 0.87 0.770.97 0.74 0.650.83
2024 19,533 24.1 12,804 20.2 0.84 0.800.87 0.80 0.750.84 0.76 0.720.81
2529 46,917 15.7 30,874 11.4 0.73 0.700.76 0.70 0.670.73 0.73 0.700.76
3034 41,935 15.2 31,452 10.8 0.71 0.690.74 0.68 0.650.71 0.72 0.680.75
35 18,093 16.5 14,209 13.6 0.82 0.780.87 0.79 0.750.84 0.84 0.780.89
Marital status
Married 61,715 10.7 41,485 7.6 0.70 0.680.73 0.68 0.650.71 0.75 0.720.79
Cohabitant 58,166 20.8 44,017 15.5 0.75 0.730.77 0.70 0.680.72 0.73 0.700.75
Single 8,807 38.4 5,146 36.6 0.96 0.911.00 0.93 0.871.00 0.86 0.790.92
Other 1,050 35.1 783 27.3 0.78 0.680.90 0.69 0.570.85 0.74 0.600.92
Maternal education level%
Elementary school 34,095 35.1 20,683 31.1 0.89 0.870.91 0.84 0.810.87 0.81 0.780.84
High school 43,265 17.3 30,363 13.8 0.79 0.770.82 0.76 0.730.79 0.75 0.720.78
University 52,115 5.6 40,188 3.5 0.62 0.580.66 0.61 0.570.65 0.60 0.560.64
Total 129,738 17.3 91,431 13.2 0.76 0.750.78
$ntotal represents Norwegian women with registered smoking habits.
$$Relative risk represents changes from period 1 to period 2.
*Odd ratio with period as independent variable.
**Odds ratio with period and all other factors in the table as independent variables.
%Among 581 women with unknown education level, 263 had registered smoking habits in 19992001, and 134 smoked daily. In 20022004,
197 had registered smoking habits, and 74 smoked daily.



































































Table II. Daily smoking at the end of pregnancy by sociodemographic variables (n259,573).
ntotal Daily smokers (%) OR1$ 95% CI OR2% 95% CI
Parity
0 104,333 13.9 1.00 Reference 1.00 Reference
1 94,227 15.2 1.11 1.081.14 1.33 1.291.37
2 44,363 17.8 1.34 1.291.38 1.64 1.581.71
3 16,650 23.5 1.90 1.821.99 1.98 1.882.09
Maternal age
B20 6,389 31.8 3.01 2.833.20 0.93 0.871.00
2024 38,103 22.6 1.88 1.821.95 1.11 1.061.15
2529 90,590 14.0 1.05 1.021.95 0.99 0.961.02
3034 86,213 13.3 1.00 Reference 1.00 Reference
35 38,278 15.2 1.17 1.131.22 0.98 0.941.02
Marital status
Married 119,778 9.5 1.00 Reference 1.00 Reference
Cohabitant 120,201 18.6 2.21 2.152.27 2.06 2.012.13
Single 17,247 37.7 5.78 5.556.01 4.31 4.124.52
Other 2,347 31.8 4.53 4.095.01 3.17 2.843.53
Maternal education level*
Elementary school 65,390 33.6 10.27 9.9110.64 7.85 7.578.15
High school 85,965 15.9 3.85 3.724.00 3.34 3.223.47
University 107,637 4.9 1.00 Reference 1.00 Reference
$OR1, Odds ratio with periods 19992001 and 20022004 as independent variables.
%OR2, Odds ratio with period and all other factors in the table as independent variables.
*Some 581 women had unknown education level.
Table III. Women reporting quitting smoking during pregnancy in relation to sociodemographic factors.
Quitters 19992001 Quitters 20022004
nsmokers$ %quitters nsmokers$ %quitters RR 95% CI
Parity
0 11,495 32.9 7,246 41.9 1.27 1.231.32
1 9,480 19.5 5,839 28.1 1.44 1.361.53
2 5,156 15.2 2,865 22.1 1.45 1.321.59
3 2,354 10.8 1,356 14.5 1.34 1.131.59
Maternal age
B20 1,502 29.8 946 35.3 1.18 1.051.33
2024 6,210 26.2 3,863 34.8 1.33 1.251.41
2529 9,432 24.7 5,277 34.4 1.39 1.321.47
3034 7,823 21.3 4,727 29.7 1.40 1.311.49
35 3,518 17.0 2,493 24.1 1.42 1.281.57
Marital status
Married 8,203 22.2 4,453 31.6 1.42 1.341.51
Cohabitant 15,756 25.3 10,094 33.7 1.33 1.281.38
Single 4,109 19.4 2,477 25.3 1.31 1.191.43
Other 417 14.9 282 25.2 1.69 1.252.30
Maternal education level%
Elementary school 14,059 16.9 8,299 23.8 1.40 1.331.48
High school 9,913 26.6 6,313 35.5 1.33 1.271.40
University 4,372 37.4 2,606 48.7 1.31 1.231.38
Total 28,485 23.4 17,306 31.8 1.36 1.321.40
$Daily smokers at the beginning of the pregnancy.
%Among women with unknown education level, 141 were daily smokers at the beginning of the pregnancy, and 8 quit smoking during
pregnancy in 19992001. In 20022004, 88 women were daily smokers at the beginning of the pregnancy, and 15 quit smoking during
pregnancy.



































































The proportion of non-responders concerning
smoking habits increased from 11.1 to 13.3% during
the study period. There was no obvious trend in age,
parity, marital status or education among the non-
responders. Regional differences showed that Oslo
and Finnmark had the highest proportion of non-
responders (28.2 and 19.4%, respectively). The
mean proportion of non-responders among all
institutions was 12.0%.
The mean birth weight was 3,566 g (SD649 g).
The birth weight of babies of non-smoking mothers,
daily smokers (at the end of the pregnancy) or non-
responders was 3,618 (624) g, 3,389 (630) g and
3,504 (719) g, respectively. Thus, babies of non-
responders had a 114 g lower birth weight compared
to babies of non-smokers, while smokers reduced the
birth weight by 229 g. If this reduction is due to
smoking, we estimated half of the non-responders to
be daily smokers at the end of pregnancy. Adding
these women to those with reported smoking habits
gave a smoking prevalence of 20.2% in the first
period and 17.9% in the second period. The
estimated proportion of smokers among non-respon-
ders did not increase during the study period when
comparing the birth weights of daily smokers and
non-smokers.
On a national basis, large differences in smoking
prevalence appeared. The county furthest north,
Finnmark, had the highest reported proportion of
smokers (24.3%) at the end of pregnancy. Oslo had
the lowest reported proportion of smokers (9.0%) at
the end of pregnancy. Including estimated smoking
habits from non-responders, smoking prevalence at
the end of pregnancy was 28.9% in Finnmark and
18.9% in Oslo.
Discussion
During the period 19992004, a substantial decline
in smoking prevalence among Norwegian pregnant
women was identified in all subgroups. During the
6-year study, a 24% decline in daily smoking at
the end of pregnancy was observed. This is less than
the percentage found in previous studies from Nor-
way (35%) and Denmark (38%) (3,5).
The smoking prevalence increased with parity,
and nulliparous quit smoking three times more often
than multiparous (3). Multiparous women who
have smoked through earlier pregnancies without
having experienced severe consequences may have a
more relaxed attitude to smoking during pregnancy.
One-third of teenage mothers smoked daily at the
end of pregnancy. In 1994/1995, a Norwegian study
found a 46% smoking prevalence among women in
the same age group (6). Similarly, studies carried out
in Denmark and Finland found high proportion of
smokers among young pregnant women (5,7). Single
women had a four times higher smoking prevalence
than married women. This is in accordance with
findings from Finland (7).
The adjusted OR for smoking at the end of
pregnancy established maternal education level as
the strongest indicator for smoking at the end of the
pregnancy (OR7.9). This is consistent with other
studies (6,8). In 1994/1995, elementary school
educated women had 5 times higher smoking pre-
valence compared to women with a university degree
(6). It seems as though there is increasing social
polarisation associated with smoking. While parity
and marital status played a certain role, maternal age
was not a decisive variable for smoking prevalence
when adjusted for other variables.
Young age and high education are mutually
exclusive. However, low education is associated
with higher prevalence of daily smoking in all age
groups. In our study, education data was last
updated in 2002. Since it is uncertain which educa-
tion level young women will achieve later in life, the
education variable is incomplete.
From 1999 to 2001, about a quarter of the women
quit smoking during pregnancy, compared to one-
third during 20022004. In 1994/1995, 38% of
pregnant women quit smoking during pregnancy
(6). Women who continue to smoke during preg-
nancy are as aware of the health risks as non-smokers
(9). Therefore, they might be more addicted to
smoking, representing a ‘hard core’ of smokers. In
an American study, more than half of the pregnant
smokers met the criteria for nicotine dependence.
The study suggested a strong association between
mental disorders and nicotine dependence among
pregnant smokers (10).
Among daily smokers, cigarette consumption was
stable during the study period (7.4 cigarettes per
day). In a previous Norwegian study, the mean
cigarette consumption decreased from 8.6 cigarettes
in 1987 to 7.0 cigarettes per day in 1994 (3).
Cigarette consumption rose with parity and maternal
age. Similarly, Wisborg et al. found a constant ratio
between pregnant women who smoked lightly and
heavily during the period 19891996 (5).
Occasional smoking was more frequent among
women with low education compared to university-
educated women. This is in contrast to the general
population, where occasional smokers are more
frequently highly educated (11).



































































The study population comprises all Norwegian
childbearing women during the period. The large
study size carries small risk of selection bias. How-
ever, for 31,199 (12%) women, no smoking habits at
the beginning or at the end of the pregnancy were
registered. The stigma associated with smoking
during pregnancy might reduce the reliance of self-
reported smoking habits. Although several factors
influence birth weight, smoking has been described
as the most important single factor for reduced
birth weight (12,13). Non-responders had babies
with a 114 g lower birth weight than babies of non-
smokers. If smoking is the most likely explanation for
this reduction, our estimation changed the daily
smoking prevalence at the end of pregnancy in
period 2 from 13.2 to 18.5%.
Daily smoking was more prevalent in Finnmark
(the most northern county), a rural part of Norway
with a large area and low population. Smoking was
least prevalent in Oslo, where more women have a
university education, which might explain a lower
smoking prevalence. On the other hand, Oslo also
had the highest rates of non-responders.
Conclusion
Despite the decline presented, reducing smoking
among pregnant women remains a challenge. Efforts
are needed to further reduce the number of pregnant
women smoking. Doctors and midwives should pay
special attention to smoking during pregnancy
among multiparous, teenage women, single women
and women with low education. The suggested role
of smoking habits of pregnant women with mental
disorders (10) should be elaborated in order to
obtain a further reduction in smoking habits during
pregnancy.
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Abstract
Background: Numerous studies have focused the association between low birthweight and later disease. Our
objective was to study the association between birthweight and later adult smoking and thereby explore a possible
mechanism for the association between low birthweight and later adult disease.
Methods: We studied associations between birthweight of women (n = 247 704) born in 1967–1995 and smoking
habits at the end of their pregnancy 13–42 years later in a prospective, population-based cohort study from The
Medical Birth Registry of Norway. Similarly, the association between birthweight of men (n = 194 393) and
smoking habits of their partners were assessed. Finally, we studied the relation between smoking habits of the
participating women and the cause specific death of their mothers (n = 222 808).
Results: Twenty per cent of women with birthweight less than 2000 g were adult daily smokers compared with 11%
with birthweight 4000–4499 g [relative risk = 1.8, 95% confidence interval 1.4, 2.2]. Similarly, we found an associa-
tion between men’s birthweight and their partners smoking habits. Mothers of smoking women had doubled risk
of dying from lung cancer and from cardiovascular disease compared with mothers of non-smoking women.
Conclusions: Being born with low birthweight is associated with smoking in adulthood. Associations of adult
smoking with partners’ birthweight and mothers’ smoking-related causes of death suggest a shared smoking
environment, and may account for some of the established association between birthweight and later cardiovascu-
lar disease.
Keywords: birthweight, fetal origin of adult disease hypothesis, maternal smoking, mortality, pregnancy, tobacco smoking.
It has been proposed that undernutrition during
pregnancy can lead to cardiovascular disease in adult
life through early programming.1 Numerous studies
have focused the association between factors in early
life, like low birthweight, and later disease.2–5 The
findings of associations between early life environ-
ment and later health and disease have evolved into
the Developmental Origins of Health and Disease
approach.6
The relation between low birthweight and adult
cardiovascular disease may also be explained by
common genetic and/or environmental factors related
both to low birthweight and adult cardiovascular
disease. Several environmental factors, including
smoking, may act in addition to or instead of early
programming. Smoking is well known to increase the
risk of both low birthweight7 and cardiovascular
disease8–10 and is, at least in recent decades, closely
related to socioeconomic level.7,10 Although studies
claim that the association between low birthweight
and adult cardiovascular disease persists even after
adjusting for socioeconomic variables, residual con-
founding cannot be excluded.2–5,11–13
The aim of this study was to examine whether
women born with low birthweight more often smoke
as adults compared with women born with higher
birthweights. To examine whether men born with low
birthweight more often live in a smoking environ-
ment as adults, we also studied their partners’
smoking habits in their pregnancies. Since partners
often share smoking habits,14 this would be an indica-
tion that also men born with low birthweight are
likely to smoke as adults. Finally, we explored the pos-
sibility of smoking as a shared environmental expo-
sure across generations, through the relation between
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women’s smoking habits and their mothers’ cause
specific mortality.
We studied birth characteristics of women and men
born from 1967 to 1995 who later were registered in
The Medical Birth Registry of Norway (MBRN) as
mothers and fathers in 1999–2009, when we had infor-
mation on maternal smoking habits during pregnancy.
Methods
We used data from the MBRN, a population based-
registry that has received compulsory notification of
all births from at least 16 gestational weeks since
1967.15 The notification form contains information on
demographic variables, the mothers’ health before
and during pregnancy, complications during preg-
nancy and delivery, and pregnancy outcomes, as well
as mothers’, fathers’ and infants’ national identifica-
tion numbers. These numbers allow linkage of
mother–father–child units in generational data files.
Women’s smoking habits at the beginning and end of
pregnancy have been registered since 1999. We chose
to focus on smoking at the end of pregnancy since
these women are more likely to stay lifelong
smokers.16 Smoking was dichotomised as non-
smoking and daily smoking.
We included 293 237 singleton women born 1967–
1995 and linked them to their first registered birth
from 1999 to 2009. Women who were registered in the
MBRN with more than one infant in this period were
thus only counted once. We excluded 29 168 (9.9%)
women with missing smoking habits and 3837 (1.3%)
occasional smokers as well as women with missing
birthweight (n = 306), birthweight less than 500 g or
more than 6000 g (n = 6) and 11 918 (4.1%) women
with missing gestational age. Gestational age was
based on the first day of the last menstrual period
and ranged from 13 to 48 weeks. To avoid mixing
reduced birthweight due to growth restriction with
that due to preterm delivery, we focused on women
born at term (≥37 weeks) when studying absolute
birthweight. Smoking has been shown to affect fetal
growth in weight primarily in the third trimester of
pregnancy.17
Z-scores for birthweight by gestational age were
computed by applying Norwegian standards for
birthweight by sex and gestational age.18 We excluded
absolute z-score values of 5 or more (n = 298) as
misclassified gestational age. For z-score analyses, the
remaining values were categorised into nine groups:
from −4.9 to 4.99 as shown in Tables 1 and 2, with
0.50–1.49 as the reference group. A total of 247 704
singleton born women and 238 488 singleton term
born women were thus the final study populations for
birthweight z-score analyses and absolute birthweight
analyses, respectively.
Table 1. Relative risks for women’s daily smoking status at the end of pregnancy by their own birthweight by gestational age z-score
among 247 704 singleton born women (both term and preterm), delivered in 1967–1995 and followed to their own pregnancy between




Daily smoking by the
end of pregnancy Unadjusted model Adjusted modela
No. No. % RR [95% CI] RR [95% CI]
−4.9, −3.51 214 50 23.4 2.02 [1.58, 2.57] 1.81 [1.42, 2.31]
−3.5, −2.51 2013 398 19.8 1.71 [1.56, 1.87] 1.61 [1.47, 1.76]
−2.5, −1.51 17 001 2970 17.5 1.51 [1.45, 1.57] 1.43 [1.37, 1.49]
−1.5, −0.51 69 785 10 102 14.5 1.25 [1.21, 1.29] 1.23 [1.19, 1.27]
−0.5, 0.49 94 669 12 046 12.7 1.10 [1.07, 1.13] 1.10 [1.07, 1.14]
0.5, 1.49 49 234 5702 11.6 1.00 Reference 1.00 Reference
1.5, 2.49 12 247 1 396 11.4 0.98 [0.93, 1.04] 0.96 [0.91, 1.02]
2.5, 3.49 2082 253 12.2 1.05 [0.93, 1.18] 0.99 [0.88, 1.11]
3.5, 4.99 459 64 13.9 1.20 [0.96, 1.51] 1.09 [0.86, 1.37]
Total 247 704 32 981 13.3
aAdjusted for the women’s mothers’ education (low: <11 years, medium 11–14 years, high (reference): >14 years) and women’s birth
order (first born (reference), second born, third born, fourth or later born) and women’s year of birth (1967–1976 (reference), 1977–1986,
1987–1995).
CI, confidence interval; RR, relative risk.
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The women’s and their mothers’ highest achieved
educational level was obtained from Statistics Norway
in 2009. Education was divided in three levels, low
(<11 years), medium (11–14 years) and high (college
or university level: >14 years). There was missing
information on education for 348 (0.14%) of the
women and 907 (0.37%) of their mothers.
Our data also contained information on men born
1967–1994. We linked a total of 228 163 singleton born
men to their first registered infant delivered in 1999–
2009 to study the relation between the men’s
birthweights and their partners’ smoking habits at the
end of their pregnancies. We excluded 21 623 (9.5%)
men whose partners had missing smoking habits and
2889 (1.4%) whose partners were occasional smokers.
We further excluded men with missing birthweight
(n = 259), birthweight more than 6000 g (n = 4) (none
had birthweight less than 500 g) and missing gesta-
tional age (n = 8736; 3.8%), as well as 259 men whose
birthweight by gestational age z-scores were 5 or
more (absolute values). The final study populations
were 194 393 singleton born men for birthweight
z-score analyses, and 186 039 singleton, term born
men for absolute birthweight analyses.
Our primary objective was to investigate the asso-
ciation between birthweight and later adult smoking.
To examine if women’s smoking was related to the
smoking habits of their mothers, we looked at the
association between women’s smoking habits in preg-
nancy and smoking-related deaths in their mothers.
We had information on cause-specific death of
mothers to 222 808 women whose smoking habits at
the end of pregnancy were registered. A secondary
objective was therefore to study the cause-specific
mortality among these mothers in relation to the
smoking habits of their daughters, for deaths occur-
ring at least 1 year after delivery. Data on cause of
death were retrieved from the national Cause of Death
Registry from 1969 until December 2009. Detailed
description of this linkage has recently been pub-
lished.19 The study was approved by the regional
ethics committee, REK VEST (2009/1868) and by the
internal review board of the MBRN.
Statistical analyses
Analyses were carried out using STATA, version 12.1
(StataCorp, College Station, TX, USA) and IBM SPSS
Statistics for Windows version 20 (IBM Corp.,
Armonk, NY, USA). Relative risks (RR) with 95% con-
fidence intervals (CI) and P-values where calculated by
using generalised linear models for the binominal
family in STATA. Our data material consists of genera-
tions, and this warrants a restrictive attitude regarding
adjustment for conventional confounding variables.
We chose to adjust for the women’s mothers’ educa-
tion as well as the women’s year of birth and birth
order, as these variables could be potential common
causes for both the women’s birthweight as well as the
women’s own smoking habits. Mothers who them-
selves where first born have been shown to smoke less
than mothers who were later born.20
Table 2. Relative risks for men having a smoking partner at the end of her pregnancy by the men’s birthweight z-score among 194 393




Partners daily smoking by
the end of pregnancy Unadjusted model
No. No. % RR [95% CI]
−4.9, −3.51 126 21 16.7 1.38 [0.94, 2.05]
−3.5, −2.51 966 158 16.4 1.36 [1.18, 1.57]
−2.5, −1.51 7428 1179 15.9 1.32 [1.25, 1.40]
−1.5, −0.51 38 117 5427 14.2 1.18 [1.14, 1.22]
−0.5, 0.49 73 434 9543 13.0 1.08 [1.05, 1.11]
0.5, 1.49 52 820 6359 12.0 1.00 Reference
1.5, 2.49 17 441 2063 11.8 0.98 [0.94, 1.03]
2.5, 3.49 3417 416 12.2 1.01 [0.92, 1.11]
3.5, 4.99 644 89 13.8 1.15 [0.95, 1.39]
Total 194 393 25 255 13.0
CI, confidence interval; RR, relative risk.
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We used Cox proportional hazards model in STATA
to study the hazard ratios for women’s mothers’ death
in strata of the women’s smoking habits at the end of
pregnancy. The proportionality assumption was veri-
fied by a log-log survival plot. We used the mothers’
age as the underlying time variable with mothers
entering follow-up at their daughters’ year of birth.
Outcomes were death from any causes, cardiovascular
death (International Classification of Diseases (ICD)
version 8 and 9: 410–414, 430–438; ICD-10: I20-I25,
G45, I60-I65, I67, I69), death from lung cancer (ICD-8
and ICD-9: 162; ICD-10: C33-34) and death from all
others causes combined. We adjusted for the mothers’
education as a possible confounder.
Results
Among our study population of 247 704 singleton
born women, 32 981 (13%) smoked daily at the end of
their pregnancy. A comparison of the population of
non-smoking and daily smoking women is provided
in Table 3. Daily smoking women were more likely to
be young, multiparous, less educated and more likely
to be of higher birth order. The daily smoking
prevalence decreased during the study period from
17% in 1999–2003 to 9.5% in 2004–2009. Women
whose mothers were less educated were more often
smokers.
Figure 1a shows smoking habits at the end of preg-
nancy by birthweight of singleton, term born women.
Women born with birthweight less than 2000 g had a
75% higher risk of smoking daily at the end of their
pregnancies than women whose birthweight was
4000–4499 g [RR = 1.8, 95% CI 1.4, 2.2]. There was a
statistically significant trend between women’s
decreasing birthweight and increasing prevalence of
adult smoking (P < 0.001).
Similarly, Figure 1b shows the relation between
birthweight of singleton, term born men and smoking
habits of their partners at the end of their pregnancies.
Table 3. Daily smoking at the end of pregnancy (13%) by various characteristics for 247 704 women borna in 1967–1995 and followed to
their own year of delivery between 1999 and 2009 in Norway
Characteristic
Non-smoking women Daily smoking women Total
No. % No. % No.
Total 214 723 87 32 981 13 247 704
Women’s year of birth
1967–1976 136 408 87 20 223 13 156 631
1977–1986 73 320 87 11 341 13 84 661
1987–1995 4995 78 1417 22 6412
Women’s year of delivery
1999–2003 109 125 83 21 845 17 130 970
2004–2009 105 598 90 11 136 9.5 116 734
Women’s birth order
First born 89 602 88 12 601 12 102 203
Second born 72 571 87 10 992 13 83 563
Third or later born 52 091 85 9300 15 61 391
Parity
0 145 332 89 17 849 11 163 181
1 48 375 84 9446 16 57 821
2+ 21 016 79 5686 21 26 702
Women’s education
Low (<11 years) 25 119 65 13 372 35 38 491
Middle (11–14 years) 76 494 84 14 745 16 91 239
High (>14 years) 112 903 96 4723 4.0 117 626
Women’s mothers’ education
Low (<11 years) 57 962 80 14 875 20 72 837
Middle (11–14 years) 112 694 88 15 119 12 127 813
High (>14 years) 43 357 94 2790 6.1 46 147
aThe women’s birth order and education and the women’s mothers’ education were missing for 547, 348 and 907 individuals,
respectively.
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Men born at term with birthweight less than 2000 g
had a 1.5 RR [95% CI 1.2, 2.0] of having a partner who
smoked daily at the end of her pregnancy, compared
with men whose birthweight was 4000–4499 g. There
was a statistically significant trend between men’s
decreasing birthweight and increasing prevalence of
adult smoking among partners (P < 0.001).
Daily smoking among pregnant women has
decreased during the last decades.21 We therefore
repeated the analyses in two consecutive periods.
During the first 5-year period (1999–2003), the RR of
daily smoking was 1.6 [95% CI 1.2, 2.0] for women
born at term with birthweight <2000 vs. 4000–4499 g,
while in the last 6-year period (2004–2009), the corre-
sponding RR was 2.0 [95% CI 1.4, 2.9].
Including preterm women, Table 1 shows the per-
centage of daily smoking at the end of pregnancy by
women’s own birthweight by gestational age z-scores.
Among women in the lowest z-score category (−4.9 to
−3.51), 23% were daily smokers as adults, compared
with 12% of women in the reference category [z = 0.5
−1.49; RR = 2.0, 95% CI 1.6, 2.6]. Adjusting for the edu-
cation of the women’s mothers as well as the women’s
birth order and the women’s year of birth slightly
attenuated the results but did not change the pattern.
Including women who reported daily smoking at the
beginning of the pregnancy gave similar but weaker
RR estimates.
The education level of the women’s mothers did not
seem to modify the results: In the highest level of
mothers’ education, women with birthweight z-scores
−2 or less had a 1.41 RR [95% CI 0.96, 2.05] of being
daily smokers as adults compared with women with
z-score 0 or higher. In the lowest level of mothers’
education, the corresponding RR was 1.5 [95% CI 1.3,
1.6]. However, the education level for the women and
their mothers was associated with the women’s
smoking habits at the end of pregnancy. Even when
women themselves had high education, their mothers’
education level was associated with her smoking
habits: Among women with high education, the pro-
portions who smoked daily at the end of pregnancy
was 2.8% and 6.1% when their mothers had high and
low education, respectively, while the corresponding
proportions among women with low education were
25% and 38%.
The relation between men’s birthweight z-scores
and smoking habits of their partners at the end of
pregnancy is presented in Table 2. Among men in the
lowest z-score category, 17% had a daily smoking
partner, compared with 12% of men in the reference
z-score category [RR = 1.4, 95% CI 0.9, 2.1].
Figure 1. Relative risk (RR) of smoking status at the end of pregnancy by women’s own birthweight among 238 488 term, singleton
women (a) and among partners to 186 039 term, singleton men by the men’s birthweight (b). Shown for women and men delivered in
1967–1995 and followed to the delivery of their own children from 1999 until 2009.
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We observed a statistically significant trend
between birthweight z-scores and adult smoking
habits for women and between birthweight z-scores
and partners’ adult smoking habits for men
(P < 0.001). The correlation between women’s and
men’s birthweight was low and could not explain this
similarity [Pearson correlation coefficient 0.023, 95%
CI 0.018, 0.027]. Among singleton men born at term
with low birthweight the RR of having a partner who
also was born singleton, at term with low rather than
high birthweight was 1.2 [95% CI 0.9, 1.7]. When
excluding partners with birthweight less than 2500 g,
the relation between men’s birthweight and partners’
smoking habits remained similar.
Finally, we looked at cause-specific death among
222 808 of the women’s mothers in strata of the
women’s smoking habits at the end of their pregnan-
cies (Table 4). For lung cancer, cardiovascular, total
death and death from all other causes combined, the
respective hazard ratios of cause specific death were
2.3 [95% CI 2.1, 2.7], 2.1 [95% CI 1.9, 2.3], 1.7 [95% CI
1.6, 1.7] and 1.5 [95% CI 1.5, 1.6] if the women were
daily smokers rather than non-smokers at the end of
pregnancies. Adjusting for the mothers’ education
slightly weakened the results. When dividing the
period into 1999–2003 and 2004–2009, the hazard ratio
estimates for all four cause-of-death categories
increased from the first to the second period but CIs
were overlapping.
Comment
In this cohort study, we have shown that women
who were born at term with a low birthweight are
more often smokers at the end of their pregnancies
than women with higher birthweights. The same
was true for growth restricted women at all gesta-
tional ages. Similar associations were found between
men’s birthweight and their partners’ smoking
habits in their pregnancies. Further, mothers whose
daughters smoked throughout pregnancy had
approximately twice the risk of dying from both
lung cancer and cardiovascular disease compared
with mothers whose daughters did not smoke as
adults.
Strengths and weaknesses of the study
An important strength of the present study is the
large size of the cohort, enabling detailed birthweight
by gestational age stratification, which showed a
dose–response relation between birthweight by gesta-
tion and later daily smoking. Also, due to the pro-
spective design, there was no retrospective recall bias
of birthweight, gestational age or smoking habits. The
population-based compulsory notification of births
made selection bias minimal. In Tables 1 and 2, we
use the complete material (term and preterm born
women and men), while in Figure 1, we use only
data for term born women and men. Gestational age
itself was, however, hardly related to later smoking
(results not shown). Preterm birth is associated with
maternal smoking, but not as strongly as low
birthweight is. Smoking-related risks for preterm
birth have been shown to be in the range 1.2–1.6
while risks for small-for-gestational-age has been
shown to be 1.5–2.9.22
Table 4. Hazard ratios for death of mothers by comparing mothers who had smoking daughters to mothers with non-smoking daugh-
ters (reference) among 222 808 mothers followed from 1967–2009
Mothers’ cause of death
Women’s smoking habits by the end of pregnancy
Non-smoking women Daily smoking women
Maternal deaths Total Maternal deaths Total Unadjusted model Adjusted modela
No. % No. No. % No. HR [95% CI] HR [95% CI]
Death from any causes 11 073 5.8 191 836 2617 8.5 30 972 1.7 [1.6, 1.7] 1.5 [1.4, 1.6]
Cardiovascular death 1453 0.76 191 836 423 1.4 30 972 2.1 [1.9, 2.3] 1.8 [1.6, 2.0]
Death from lung cancer 990 0.52 191 836 321 1.0 30 972 2.3 [2.1, 2.7] 2.0 [1.7, 2.2]
Death from all other causes combined 8647 4.5 191 836 1881 6.1 30 972 1.5 [1.5, 1.6] 1.4 [1.3, 1.5]
aAdjusted for the women’s mothers’ education (low <11 years, medium 11–14 years, high (reference) >14 years).
CI, confidence interval; HR, hazard ratio.
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Our population had a relatively high proportion of
missing smoking habits (9.9%). However, missing
smoking habits was only weakly associated with low
birthweight [RR = 1.1, 95% CI 1.03, 1.2].
Among women where smoking information was
missing, mean birthweight of their singleton infants
was reported to be 114 g lower than among non-
smoking women, compared with 229 g lower among
daily smoking women, which indicates that approxi-
mately half of the women with missing smoking
habits were smokers.21 In a sensitivity analysis, we
assigned all women with missing information on
smoking habits to be daily smokers. This reclassifica-
tion did not change the dose–response pattern
although it attenuated the results. We excluded occa-
sional smokers from analyses as a previous study
found that 66% of women reporting occasional
smoking had cotinine values suggesting daily
smoking.23
Maternal smoking during pregnancy has only been
registered in the MBRN since 1999. Therefore, we could
not study the smoking habits of the women’s mothers
directly. However, previous studies have shown that
maternal smoking is linked through generations.24–26 A
recent Norwegian study found an inverse association
between offspring birthweight and grandparental car-
diovascular mortality, but this was considerably weak-
ened after adjusting for maternal smoking during
pregnancy.27 They also showed an inverse association
between birthweight and lung cancer and chronic
obstructive pulmonary disease. Recently, Smith et al.28
concluded that so far there is no study that includes
medical records of birthweight and gestational age, that
appropriately takes life style habits and socioeconomic
status into account and that includes disease incidence
or cause of death as end points. We have focused a
factor that has not been available when studying the
relation between low birthweight and adult cardiovas-
cular disease: smoking habits passed on through gen-
erations. By using smoking-related mortality among
mothers as a proxy for their smoking habits, we suggest
that maternal smoking is a common cause of offspring
low birthweight as well as offspring’s smoking
habits in adulthood. The latter will be an important risk
factor for cardiovascular disease, and accordingly,
transgenerational smoking habits could explain parts of
the association between low birthweight and later car-
diovascular disease. Thus, studies describing this rela-
tion need to be able to adjust appropriately for smoking
habits.
Comparisons to other studies
It has been argued that the early programming
hypothesis is too general and has inconsistent
support.29 Also, it has been suggested that socioeco-
nomic factors and smoking are possible mediators that
may explain the association.30,31 Low birthweight is
related to socioeconomic level both at birth32 and later
in life33 and adjusting for adult deprivation have been
shown to weaken the relation between infant and
adult mortality rates.34 Low childhood socioeconomic
position has been shown to predict later smoking, an
association partly explained by educational level.35
However, several ‘early origin studies’ state that
adjustment for smoking has been done.2–5,12,13,36 Besides
the Nurses’ Health Study,3 these studies have below
1500 participants. In the Nurses’ Health Study with
70 297 participants, the authors adjust for smoking as a
confounding factor both for the nurse and the nurse’s
mother without a considerable change in the inverse
association between the extremes of self-reported
birthweight and cardiovascular disease.3 However,
adjusting for an intermediate variable using traditional
statistical models is questionable and biased associa-
tions cannot be excluded.37,38
In our study, we found that birthweight was related
to adult smoking habits both directly and indirectly
through partners’ smoking habits in pregnancy. A pre-
vious study from the MBRN showed low correlation
between mothers’ and fathers’ birthweight.39 Given
this low correlation and the persistent association
after excluding partners whose own birthweight was
very low, this may reflect spousal selection on
smoking status.14 Since smoking in pregnancy is asso-
ciated with intrauterine growth restriction, these find-
ings indicate that children born with low birthweight
seem to share environmental risk factors that are cul-
turally dependent. This suggests smoking as a shared
environmental exposure across generations, and that
the mothers’ smoking contributed to low birthweight
in their offspring. The birthweight–smoking associa-
tion among women was observed in both the highest
and the lowest level of their mothers’ education, and
indicates that smoking habits are ‘inherited’ irrespec-
tive of socioeconomic status. In an adjusted model
where we consider women’s own education as a
proxy for their socioeconomic status and included it
as an adjustment variable, the RRs somewhat attenu-
ated, but the pattern remained evident (data not
shown).
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Some studies have claimed no association between
birthweight and adult smoking.3,12,13 However, the
association between birthweight40 and weight at
1 year of age41 and later adult smoking habits has pre-
viously been mentioned. Some of these studies are
commenting on the association between birthweight
and smoking habits among men only.12,41 Others have
information on birthweight only from self-report3 and
do not have data on gestational age.13,40 The relation
between birthweight and adult smoking is influenced
by different overall smoking prevalences between
populations as well as different time periods within a
population. Different birth cohorts appear to have dis-
similar patterns of smoking habits42 and Great Britain
and the US experienced both an earlier tobacco epi-
demic as well as higher consumptions than Norway.43
We studied women born in 1967–1995 and their
smoking habits between 1999 and 2009. Thus, our
cohort of women is younger than women in most
other studies.3,4,13,40,44–46 Among pregnant women in the
Norwegian Mother and Child Cohort Study, 20% of
those born in 1954–1965 reported being exposed to
cigarette smoke in utero, compared with 32% among
those born in 1981–1992.47 For the general female
population in Norway, the peak smoking prevalence
was 10% for the early 1890s cohort, 52% for the early
1940s cohort and 41% for the early 1960s cohort.42
In this study, we had the opportunity to quantify
the association between z-scores for birthweight by
gestational age and adult smoking habits in a large
material. This study shows that birthweight is associ-
ated with smoking habits in adulthood. It is therefore
essential that research relating birthweight to later
health outcomes provide a proper control for smoking
habits both of the mother during pregnancy and in
adulthood for the individual under study. The women
in our study were too young to allow us to study the
relation between their birthweight and their own
long-term cardiovascular morbidity and mortality
with adequate power. Future studies will be able to
look at a person’s whole lifetime and could study how
birthweight and later smoking habits are related to
cardiovascular disease.
Conclusion
In conclusion, being born with low birthweight is
associated with smoking in adulthood. Associations of
adult smoking with partners’ birthweight and
mothers’ smoking-related causes of death suggest
a shared smoking environment, and may account
for some of the established association between
birthweight and later cardiovascular disease.
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Abstract
Background: Smoking during pregnancy is linked to having a small for gestational age (SGA) baby. We estimated
SGA risk among women who smoked persistently, quit smoking or started smoking during their first two
pregnancies.
Methods: Data from the population-based Medical Birth Registry of Norway was used to evaluate self-reported
smoking at the beginning and end of two successive pregnancies among 118 355 Nordic women giving birth
1999–2014. Relative risks (RR) with 95% confidence intervals (CI) of SGA in the second pregnancy were estimated
using adjusted generalised linear models with non-smokers during both pregnancies serving as referent category.
Results: Daily smokers throughout both pregnancies had almost threefold increased SGA risk in the second
pregnancy (RR 2.9, 95% CI 2.7, 3.1). Daily smokers in the first pregnancy, who abstained in the second, had a
1.3-fold increased risk (95% CI 1.1, 1.5). Intermediate risks were found among persistent daily smokers who quit
by the end of the second pregnancy (RR 2.0, 95% CI 1.6, 2.4) and non-smokers in first pregnancy who smoked
daily throughout their second (RR 1.8, 95% CI 1.4, 2.3). Persistently smoking women without SGA in first
pregnancy, had a 2.7-fold increased risk of SGA in second pregnancy (95% CI 2.5, 3.0).
Conclusions: Smoking throughout two successive pregnancies was associated with the greatest increased SGA risk
compared with non-smokers, while cessation before or during the second pregnancy reduced this risk. Women
who smoked in the first pregnancy without experiencing SGA are not protected against SGA in second pregnancy
if they continue smoking.
Keywords: pregnancy, infant small for gestational age, risk factors, perinatal, smoking.
Small for gestational age (SGA) is most commonly
defined as birthweight below the 10th percentile for
gestational age and sex1,2 and is a marker for
restricted fetal growth. SGA infants have an increased
risk of morbidity3 and mortality.4,5 SGA can represent
underlying pathology such as pregnancy complica-
tions or maternal conditions associated with placental
dysfunction.6 Smoking is one of the most important
modifiable risk factors for SGA7,8 and a causal rela-
tionship between smoking and fetal growth restriction
is well established.7 The Medical Birth Registry of
Norway (MBRN) has since 1999 registered maternal
smoking status at the beginning and end of preg-
nancy, allowing us to characterise smoking status at
four time points across two subsequent pregnancies.
Having two measures of smoking (one at the begin-
ning and one at the end of pregnancy) is important
because some women are unable to quit smoking
immediately and others may quit but resume smoking
before the end of the pregnancy. Reliance on one mea-
sure, therefore, inevitably leads to some misclassifica-
tion of exposure among women attempting to quit. To
the extent that misclassification occurs, estimates
between maternal smoking and outcomes may be
obscured. More detailed knowledge of the timing of
maternal smoking and SGA risk would be informative
for advising pregnant smokers and guiding smoking
cessation campaigns. To our knowledge, the risk of
SGA associated with early and late maternal smoking
across two pregnancies has not yet been reported.
The main aim of our study was to estimate risk of
SGA in a second pregnancy among women who
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smoked persistently, quit smoking, or started
smoking during the first two pregnancies compared
to non-smokers. A secondary aim was to assess if
daily smoking women throughout the first pregnancy,
without a growth restricted infant, were ‘protected’
against growth restriction in the next pregnancy if
they continued smoking.
Methods
Data source and study population
The MBRN is a mandatory nationwide population-
based registry of all births from 16 weeks’ gestation.9
Starting at the first antenatal visit a midwife or a doc-
tor fills in an antenatal chart that follows the woman
throughout her pregnancy. The chart contains infor-
mation about demographic data, reproductive history,
medical conditions, complications during pregnancy,
and lifestyle habits. Self-reported smoking status at
the beginning and at the end of pregnancy is obtained
through interview. At the time of delivery a midwife
transfers information from the antenatal chart to the
MBRN notification form. On this form, maternal
smoking status is registered by checkboxes as non-
smoker, occasional smoker (less frequent than daily),
or daily smoker. For daily smokers the number of
daily smoked cigarettes is recorded. Checkboxes
transfer more valid information to registries than writ-
ten text.10 Maternal age at first birth, marital status,
mothers’ country of birth, and gestational age were
available from the MBRN. Gestational age was based
on the first day of the last menstrual period (LMP). If
LMP was missing or the difference between LMP and
ultrasound was more than 10 days, gestational age
was based on second trimester ultrasound measure-
ments. Maternal education in 2009 was derived from
the National education database at Statistics Norway
through record linkage in a subset of the study popu-
lation, using the mother’s unique national identifica-
tion number.
Study population
Our study population consisted of 220 413 women
having their first and second singleton birth in 1999 to
2014 (Figure S1). The two births were linked to their
mother using the mother’s unique national identifica-
tion number (included in the MBRN notification
forms for all births), and the mother with her
successive pregnancies was the observation unit. Our
study included only women born in Norway, Sweden,
Denmark, Finland, and Iceland, excluding 33 503
women. The offspring of women born outside these
Nordic countries weighed an average of 119 g less
than babies born to Nordic women (t-test P < 0.005),
and they would therefore more likely be classified as
SGA using Norwegian standards even without
intrauterine growth restriction. We further excluded
women with missing data on infant sex, birthweight,
or gestational age and women with spontaneous abor-
tion (<22 weeks and birthweight <500 g) (n = 2012).
After exclusion of women with missing data on smok-
ing at the end of pregnancy (n = 59 909) or occasional
smokers at the end of pregnancy (n = 2510), our main
analyses included 122 479 women with valid smoking
status at the end of each of the two pregnancies
(Tables 1 and 2). For the analyses on smoking status
early and late in two pregnancies, exclusions were
women with missing smoking status for these time
points (n = 60 431), occasional smokers (n = 5805),
and women with unusual smoking trajectories
(n = 307), leaving 118 355 women with valid smoking
status at the beginning and end of the two pregnan-
cies (Table 3, Figure 1).
Giving birth to an SGA infant is a strong risk factor
for recurrent SGA. To avoid mixing the effect of smok-
ing with other causes of recurrent SGA, we did addi-
tional analyses restricted to women without SGA in
the first pregnancy (n = 106 468 women, Table 3), and
analysed separately women with SGA in their first
pregnancy (n = 11 087).
Maternal education was only available for mothers
giving birth during 1999–2010, which amounted to
76 161 women with available birthweight, gestational
age, and smoking status. Analyses evaluating a possi-
ble different effect of smoking on SGA by level of edu-
cation were done in this subset, while the main
analyses were done on the total study population
(1999–2014).
Statistical analyses
Generalised linear models for the binominal family
were used to compute relative risks (RR) with 95% CI
for the association between smoking status in two
pregnancies and the risk of SGA in the second. SGA
was defined as birthweight by gestational age below
the 10th percentile based on Norwegian gender speci-
fic birthweight standards.2 We first examined
© 2016 John Wiley & Sons Ltd
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categories of smoking based on the status at the end
of two successive pregnancies; persistent non-smokers
(No-No), quitters from first to second pregnancy
(Daily-No), starters from first to second (No-Daily),
and persistent smokers (Daily-Daily) (Table 2). We
then examined more complex categories taking into
account status at the beginning and at the end of the
two successive pregnancies (Table 3). Women who
were non-smokers throughout both pregnancies were
the referent group. Based on causal diagrams and
directed acyclic graph (DAG) theory,11 maternal age
at first birth (<20, 20–24, 25–29, 30–34, 35 + years),
marital status at first birth (married, cohabitating, sin-
gle, widow/other/missing), year of first birth (1999–










Total 122 479 100 5972 100% 4.9
Smoking status at the end of first pregnancy & second pregnancy
No & No 110 189 90.0 4765 79.8 4.3 <0.01
Daily & No 4253 3.5 269 4.5 6.3
No & Daily 1865 1.5 171 2.9 9.2
Daily & Daily 6172 5.0 767 12.8 12.4
Maternal age first pregnancy
<20 6044 4.9 395 6.6 6.6 <0.01
20–24 31 430 25.7 1649 27.6 5.3
25–29 52 177 42.6 2329 39.0 4.5
30–34 27 261 22.3 1304 21.8 4.8
35+ 5567 4.6 295 4.9 5.3
Marital status first pregnancy
Married 36 012 29.4 1655 27.7 4.6 <0.01
Cohabiting 76 374 62.4 3680 61.6 4.8
Single 8608 7.0 552 9.2 6.4
Widow/other/missing 1485 1.2 85 1.4 5.7
Previous SGA in first pregnancy b 11 458 9.4 2149 36.3 18.8 <0.01
Maternal educationc
Low education (<11 years) 10 261 13.5 738 18.6 7.2 <0.01
High education (≥11 years) 65 900 86.5 3231 81.4 4.9
aP-values refer to testing of independence between the respective factor and SGA status (second pregnancy) using Pearson’s chi square
test(ᵡ2).
b845 (0.7%) women had no information on prior SGA, of these 49 women had SGA in the second pregnancy.
cHighest achieved education was obtained in 2009. Education was missing for 504 (0.7%) women in subset of the study population with
available information on education 1999–2010.
Table 2. The Risk of small for gestational age (SGA) (10th and 2.5th Percentile) in the second pregnancy among Nordic born women
with two successive singleton pregnancies by smoking status at the end of both pregnancies. Norway, 1999–2014
Smoking status end of first &
second pregnancy Total
SGA 10th percentile in second pregnancy SGA 2.5th percentile in second pregnancy
n % RR (95% CI) aRRa (95% CI) n % RR (95% CI) aRRa (95% CI)
No & No 110 189 4765 4.3 1.0 (Reference) 1.0 (Reference) 847 0.8 1.0 (Reference) 1.0 (Reference)
Daily & No 4253 269 6.3 1.5 (1.3, 1.6) 1.5 (1.3, 1.7) 49 1.2 1.5 (1.1, 2.0) 1.5 (1.1, 2.0)
No & Daily 1865 171 9.2 2.1 (1.8, 2.5) 2.1 (1.8, 2.5) 46 2.5 3.2 (2.4, 4.3) 3.1 (2.3, 4.2)
Daily & Daily 6172 767 12.4 2.9 (2.7, 3.1) 2.9 (2.7, 3.1) 191 3.1 4.0 (3.4, 4.7) 3.9 (3.3, 4.6)
Total 122 479 5972 4.9 1133 0.9
aAdjusted for maternal age, marital status and year of first birth.
© 2016 John Wiley & Sons Ltd
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2007, 2008–14) and maternal education (highest
achieved education: ≤10 years and ≥11 years) were
considered possible confounders for the association
between maternal smoking and SGA in the second
pregnancy (DAG in Figure S2). We adjusted for
maternal age, marital status, and year of first birth.
We repeated analyses defining SGA as birthweight
below the 2.5th percentile, and performed separate
analyses examining term pregnancies (≥37 gestational
weeks). Analysing term deliveries alone excluded an
important possible selection bias as the proportion of
missing smoking information at the end of the second
pregnancy was higher in preterm than term gestations
(41%, 25% and 18% in 23 weeks, 30 weeks, and term
gestations respectively).
To evaluate smoking dosage in different smoking
categories, two sample t-tests comparing group means
(number of cigarettes smoked daily) were performed.
Pearson’s chi square test P-values were used to test
the independence between the respective factors and
SGA status in second pregnancy. In separate analyses
investigating patterns of missing smoking informa-
tion, SGA risk in second pregnancy was estimated
among women with missing values for any of the four
registration points of their two first pregnancies.
All analyses were performed with STATA, version
14.0 Intercooled for Windows (StataCorp LP, College
Station, Texas).
The study was approved by Regional Ethical Com-
mittee (2009/1868 and 2015/1728).
Results
Maternal characteristics
Among 122 479 women, 4.9% had an SGA infant in
their second pregnancy. Most women had their first
child at the ages of 20–34 years and were married or
cohabiting (Table 1). Of women with registered smok-
ing status, 90% were non-smokers at the end of both
Table 3. The risk of small for gestational age (SGA) (10th percentile) in the second pregnancy, all second and term infants among




SGA in second pregnancy







Pregnancy Total n % RR (95% CI) aRRa (95% CI) RRa(95% CI) aRRa(95% CI)
1 No-No No-No 99 733 4274 4.3 1.0 (Reference) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
2 Daily-No No-No 5185 254 4.9 1.1 (1.0, 1.3) 1.2 (1.0, 1.3) 1.2 (1.0, 1.3) 1.1 (0.9, 1.3)
3 Daily-Daily No-No 2790 156 5.6 1.3 (1.1, 1.5) 1.3 (1.1, 1.5) 1.3 (1.1, 1.6) 1.2 (1.0, 1.5)
4 No-No Daily-No 1025 52 5.1 1.2 (0.9, 1.5) 1.2 (0.9, 1.6) 1.2 (0.9, 1.6) 1.4 (1.0, 1.9)
5 Daily-No Daily-No 936 47 5.0 1.2 (0.9, 1.6) 1.2 (0.9, 1.6) 1.3 (1.0, 1.7) 1.3 (0.9, 1.8)
6 Daily-Daily Daily-No 1087 92 8.5 2.0 (1.6, 2.4) 2.0 (1.6, 2.4) 2.0 (1.6, 2.5) 2.0 (1.5, 2.5)
7 No-No Daily-Daily 739 57 7.7 1.8 (1.4, 2.3) 1.8 (1.4, 2.3) 1.9 (1.5, 2.5) 1.7 (1.3, 2.4)
8 Daily-No Daily-Daily 901 99 11.0 2.6 (2.1, 3.1) 2.6 (2.1, 3.1) 2.7 (2.2, 3.3) 2.4 (1.9, 3.1)
9 Daily-Daily Daily-Daily 5959 740 12.4 2.9 (2.7, 3.1) 2.9 (2.7, 3.1) 3.0 (2.8, 3.3) 2.7 (2.5, 3.0)
Total 118 355 5771 4.9
aAdjusted for maternal age, marital status and year of first birth.
No−No            No−No
Daily−No         No−No
Daily−Daily      No−No
No−No            Daily−No
Daily−No         Daily−No
Daily−Daily      Daily−No
No−No            Daily−Daily
Daily−No        Daily−Daily
Daily−Daily     Daily−Daily
early−late in 1st and 2nd pregnancy
Smoking status
10.8 1.5 2 3 4
Adjusted relative risk
Figure 1. The Adjusted Relative Risk for SGA (10th Percentile)
in second pregnancy among women born in the Nordic coun-
tries with two successive pregnancies with singleborns in the
period 1999–2014. Persistent non-smokers as reference group.
© 2016 John Wiley & Sons Ltd
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pregnancies, 5% were persistent daily smokers at the
end of both pregnancies, 3.5% quit smoking from the
first to the second pregnancy and 1.5% were non-
smokers at the end of first pregnancy and daily smok-
ers at the end of second pregnancy. Being younger
than 30 years and not married when delivering the
first child were both associated with being a persistent
smoker (data not shown). Comparing women with
and without SGA in the second pregnancy, those with
an SGA infant were more likely to smoke, were
younger, were more often single and with low educa-
tion. Women with SGA in first pregnancy had
increased risk of giving birth to an SGA infant also in
the second compared to women without SGA in the
first pregnancy (RR 5.5, 95% CI 5.2, 5.8).
Smoking status at the end of pregnancies only
Compared to women who did not smoke at the end of
their first two pregnancies, women who smoked daily
at the end of two successive pregnancies (persistent
smokers) had an almost threefold increased risk of
having a SGA baby (10th percentile) in the second
pregnancy (Table 2). Adjustment for maternal age,
marital status, and year of first birth resulted in a sim-
ilar estimate. Women who reported non-smoking at
the end of the first pregnancy and daily smoking at
the end of second pregnancy (starters) also had a
higher risk compared with non-smokers, although the
risk ratio was smaller than persistent smokers.
Women who smoked daily at the end of the first preg-
nancy but were non-smokers at the end of their sec-
ond pregnancy (quitters) had a significantly smaller
increase in risk of SGA in the second pregnancy.
When defining SGA below the 2.5th percentile, quit-
ters had a similar risk of SGA in the second preg-
nancy, while persistent smokers and starters had an
even higher relative risk (Table 2).
Smoking status at the beginning and end of the two
pregnancies
Women who smoked throughout the first pregnancy,
but were non-smokers throughout their second preg-
nancy (Category 3), had a modestly increased risk of
SGA in the second pregnancy. Women who were
daily smokers at the beginning of each pregnancy and
quit smoking by the end of each (Category 5) did not
have significantly increased risk of SGA in the second
pregnancy compared to persistent non-smokers
(Category 1), while those who were non-smokers in
first pregnancy, but smoked daily throughout their
second (Category 7), had a 80% increased risk of a
SGA infant in the second pregnancy. Women who
smoked daily throughout their first pregnancy and
at the beginning, but not the end of the second
pregnancy (Category 6), had a twofold risk of SGA
in the second pregnancy, however, this risk was
significantly smaller than persistent smokers (Cate-
gory 9). Relative risks were similar when restricting
analyses to only term births in the second preg-
nancy. Among women without SGA in their first
pregnancy, persistent daily smokers (Category 9)
had 2.7 times the risk of SGA in the second preg-
nancy, compared to persistent non-smokers (Cate-
gory 1). The risk for SGA in second pregnancy in
Category 2 and 3 was no longer statistically signifi-
cant among women without SGA in the first preg-
nancy. Among women with SGA in the first
pregnancy (data not shown), persistent smoking
was also associated with an increased risk of SGA
in the second pregnancy, but the RR estimate was
smaller than among those whose first birth was not
SGA (RR 1.8, 95% CI 1.6, 2.0), although the baseline
risk was higher for these women. In a sensitivity
analysis we excluded women with preeclampsia in
the second birth and the results were essentially
unchanged.
Number of daily cigarettes
In Table 3 three smoking trajectories had daily smok-
ing at the end of second pregnancy. The mean number
of daily cigarettes smoked at the end of the second
pregnancy in the Daily-Daily-Daily-Daily category was
7.8 (95% CI 7.6, 7.9), while it was 6.3 (95% CI 6.1, 6.6)
in the Daily-No-Daily-Daily category and 5.8 (95% CI
5.5, 6.1) in the No-No-Daily-Daily category, being sig-
nificantly higher among the persistent smokers than
in each of the other categories. The mean number was
also significantly higher in the Daily-No-Daily-Daily
category than in the No-No-Daily-Daily category
(P < 0.05).
Education
There was a strong association between persistent
smoking and SGA in the second pregnancy both
among women with low and high education
(Table S1). Using non-smoking women with high
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education as the common reference, the highest point
estimate RR was found for persistent smokers with
low education. However, we found no interaction
effects between smoking and maternal education on
the risk for SGA in second pregnancy. The results
remained similar when further adjusting for educa-
tion in the main analyses (as of Table 3). Although the
differences in educational level in the proportion of
women with SGA in second pregnancy were small for
several of the smoking categories, the proportion of
women in categories of daily smoking were much
higher in low than in high education; 18.6% of all
women with low education were in category 9 (Daily-
Daily-Daily-Daily), while only 3.3% of women were
present with high education.
Missing smoking status
For the 184 898 women with two successive singleton
births in the period 1999–2014, a total of 9820 (5.3%)
had missing smoking status at the end of both
pregnancies, while 50 089 (27.1%) had missing in one
of the pregnancies. Compared to persistent non-
smokers, women who were daily smokers in the first
pregnancy and had missing smoking status in the sec-
ond had a twofold increased risk of SGA in the second
pregnancy (aRR adjusted relative risk) 2.2, 95% CI 1.9,
2.6) (Table S2, Figure S3). The risks in other trajecto-
ries are also reported.
Among women who did not have SGA in second
pregnancy, 17.6% had missing smoking data for the
end of second pregnancy, while this percentage was
18.8% among those with SGA in second pregnancy
(RR 1.1, 95% CI 1.0, 1.1).
SGA and potential changes in smoking habits
We explored the possibility that smoking followed by
SGA in the first pregnancy may have reduced the
probability of smoking in the second pregnancy.
Among women who smoked at the end of the first
pregnancy and gave birth to an SGA infant, 64.5%
continued to smoke throughout the end of second
pregnancy, compared to 58.2% of daily smokers in the
first pregnancy without SGA in the first pregnancy
(RR 1.1, 95% CI 1.1, 1.2). Experiencing SGA in the first
pregnancy was therefore not associated with a higher
probability of smoking cessation. We did find that
daily smoking women who experienced SGA in first
pregnancy, smoked a higher average number of
cigarettes daily than daily smoking women without
SGA in first pregnancy: 7.1 (95% CI 6.9, 7.3) vs. 6.5
(95% CI 6.5, 6.6) (P < 0.05).
Comment
Main findings
We found the highest relative risks of SGA in the sec-
ond pregnancy in trajectories with smoking in the sec-
ond pregnancy. We found that women who smoked
throughout two pregnancies had close to threefold
higher risk of SGA in the second pregnancy than non-
smokers. Quitting smoking at any time before the end
of the second pregnancy was associated with smaller
risk increases. Even women who smoked throughout
the first pregnancy and in the beginning of the second,
but quit before the end, had a significantly smaller
increased risk than persistent smokers, although twice
the risk of non-smokers. Women who smoked daily in
the first pregnancy, but not in the second had a mod-
estly increased risk of SGA in the second pregnancy.
Women who smoked in the first pregnancy without
experiencing SGA had a more than twofold risk of
SGA in the second pregnancy if they continued smok-
ing. We found heterogeneous risk patterns in the dif-
ferent smoking trajectories throughout two successive
pregnancies, suggesting that smoking information
across four time points better characterised risk of
SGA in the second pregnancy than using information
only in the beginning or end of the pregnancy. The
average number of cigarettes smoked daily at the end
of the second pregnancy also differed significantly
between women with different smoking trajectories;
persistent smoking in two pregnancies having the
highest dose. The association between persistent
smoking and recurrent SGA was slightly weaker than
associations in the total study population, suggesting
that in women with previous SGA other factors caus-
ing SGA dilute the effect of smoking.
Comparisons with other studies
Smoking is a risk factor for SGA as well as for the
morbidity in SGA infants.3 Baba et al.12 found similar
associations between smoking during one pregnancy
and term SGA (OR 3.2, 95% CI 3.0, 3.4) as we found
among women smoking throughout two pregnancies
(RR 3.0, 95% CI 2.8, 3.3). They studied changes in
smoking habits within one pregnancy, and found that
© 2016 John Wiley & Sons Ltd
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women who quit smoking early in pregnancy had
lower risk of SGA than women who quit late. Our
results based on smoking information at two time
points in two successive pregnancies is consistent
with Baba’s finding: Women who smoked daily in
their first pregnancy and in the early stage of their sec-
ond, had a significantly smaller increase in risk of
SGA in the second pregnancy than persistent daily
smokers, although twice the risk compared to non-
smokers. Women who smoked at the beginning of
pregnancy, but managed to quit by the end in both
pregnancies did not have a significantly increased risk
of SGA in the second pregnancy.
Nordstr€om et al.13 looked at smoking in two suc-
cessive pregnancies and differences in sibling birth-
weight. Using smoking data from the first antenatal
visit in two pregnancies, they reported an increased
birthweight in the second infant among women who
smoked heavily in first pregnancy and then quit
smoking. Our study using smoking across four time
points in two pregnancies shows that women who
smoked at the beginning of the first pregnancy
could have several different smoking trajectories
throughout the first and second pregnancy. These
trajectories differed in risk of SGA in the second
pregnancy; the women in the category Daily-Daily-
No-No had a 30% increased risk of having an SGA
baby, while women in the category Daily-Daily-
Daily-No had a twofold risk. We also found that
women who reported non-smoking at the end of
first pregnancy and daily smoking at the end of sec-
ond pregnancy differed in the risk of SGA according
to the four time point trajectories.
Strengths and limitations
The mandatory reporting of all births to the MBRN
diminished the possibility of selection bias. Data on
smoking status were prospectively collected which
minimises recall bias. We used family-based data (sib-
files) and had information on smoking status in two
successive pregnancies (early and late in each gesta-
tion), giving a unique depiction of women’s smoking
trajectories throughout the two pregnancies.
We have previously found self-reported smoking
status to be a valid marker for tobacco exposure by
comparing self-reported smoking status against
plasma cotinine in a subset of a large Norwegian
cohort study.14 However, the hazards of smoking dur-
ing pregnancy are well known and women may wish
to portray themselves in a better light and underesti-
mate how much they smoke. Women may also refuse
to report their smoking status. The risks of SGA in sec-
ond pregnancy were increased in several of the trajec-
tories where missing smoking status was combined
with daily smoking at least once across the four time
points, suggesting that the presented risk of SGA
associated with smoking is a conservative estimate.
Although the percentage of women with missing data
on smoking habits in second pregnancies were
slightly higher when the infant was SGA than not, the
difference was so small that it should not have biased
our results by much.
Although we were able to adjust for important
potential confounders like maternal education,
residual confounding cannot be ruled out. Informa-
tion on maternal height and pre-pregnancy weight
were not available. The modestly increased risk
among women who were daily smokers in the first
pregnancy and non-smokers in the second preg-
nancy, raises the question whether tobacco smoke
has a direct toxic effect only during the pregnancy
exposed or if it persists to the next pregnancy.
Although we cannot rule out a tobacco effect, these
women who smoked during pregnancy likely differ
from non-smokers in other health-related beha-
viours associated with SGA.
When restricting analyses to women who did not
give birth to an SGA infant in the first pregnancy, we
may open a backdoor path through the unmeasured
genetic factors that are causally related to SGA in the
first and second pregnancy and introduce bias to the
estimate.15 However, the estimates remained similar
after stratification suggesting that the amount of bias
was minimal.
Conclusions
Quitting smoking from one pregnancy to the next
reduced the risk of SGA in the second pregnancy.
Even quitting before the end of the second pregnancy
reduced the risk compared to persistent smokers,
although the risk was still almost twice the risk of
non-smoking women. Women who smoked in two
successive pregnancies were at higher risk of having
an SGA baby in their second pregnancy compared to
women who smoked in only the second pregnancy.
Women who smoked in the first pregnancy without
experiencing SGA are not protected against SGA in
the second pregnancy if they continue to smoke.
© 2016 John Wiley & Sons Ltd
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